世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

末梢血管用デバイス市場：タイプ別（血管形成術バルーン＆ステント、カテーテル、血管内動脈瘤修復ステントグラフト、プラーク修正デバイス、ガイドワイヤー、血管閉鎖デバイス、バルーン膨張デバイス）-2026年までの世界予測


Peripheral Vascular Devices Market by Type (Angioplasty Balloon & Stent, Catheters, Endovascular Aneurysm Repair Stent Grafts, Plaque Modification Devices, Guidewires, Vascular Closure Devices, Balloon Inflation Devices) - Global Forecast to 2026

末梢血管用デバイスの世界市場規模は、2021年の103億米ドルから2026年には134億米ドルに達すると予測され、2021年から2026年までのCAGRは5.3％と予想されています。この市場の成長は、高齢者人口の急増とそれに伴... もっと見る

　

　

出版社 出版年月 電子版価格 ページ数 図表数 言語
MarketsandMarkets
マーケッツアンドマーケッツ 		2021年12月8日 US$4,950
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら 		330 542 英語

日本語のページは自動翻訳を利用し作成しています。


　

サマリー

末梢血管用デバイスの世界市場規模は、2021年の103億米ドルから2026年には134億米ドルに達すると予測され、2021年から2026年までのCAGRは5.3％と予想されています。この市場の成長は、高齢者人口の急増とそれに伴う末梢血管疾患の有病率の上昇、末梢血管処置に対する有利な償還シナリオ、製品承認数の増加、糖尿病有病率の上昇、タバコ消費率の上昇などが要因となっています。
予測期間中に最も高い成長を遂げる製品セグメント「血行力学的血流変更装置」。
製品に基づき、末梢血管デバイス市場は、血管形成術バルーン、血管形成術ステント、カテーテル、血管内動脈瘤修復ステントグラフト、下大静脈フィルター、プラーク修正デバイス、血行動態変更デバイス、その他の末梢血管デバイスに区分されます。塞栓防止装置セグメントは、予測期間中に最も高いCAGRで成長すると予測されます。この市場の成長に寄与する主な要因は、新技術開発への投資の増加、これらのデバイスに対する規制当局の承認数の増加、および先進的なEPDの開発に対するベンチャーキャピタルの資金提供です。

"アジア太平洋地域は予測期間中に最も高いCAGRを記録すると推定される。"
本レポートでは、末梢血管機器市場を北米、欧州、アジア太平洋地域、その他の地域（RoW）の4つの主要地域セグメントに分けています。アジア太平洋地域の市場は、予測期間中に最も高い成長率を記録すると予測されます。この市場の成長は主に、高齢者人口の増加、低侵襲手術の利点に関する外科医の意識の高まり、およびいくつかのAPAC諸国における対象疾患の患者数の増加によってもたらされています。

供給側一次面接の内訳、企業タイプ別、呼称別、地域別。

- 企業タイプ別ティア1（32％）、ティア2（44％）、ティア3（24％）。

- 職位別Cレベル(30%)、ディレクターレベル(34%)、その他(36%)

- 地域別北米(40%)、欧州(28%)、アジア太平洋(20%)、その他の地域(12%)


レポート掲載企業一覧

- メドトロニック（アイルランド）
- ボストン・サイエンティフィック・コーポレーション（米国）
- アボット社（米国）
- ベクトン・ディッキンソン アンド カンパニー（米国）
- テルモ株式会社（日本）
- カーディナル・ヘルス社（米国）
- B. Braun Melsungen AG (米国)
- メリットメディカルシステムズ（米国）
- ペナンブラ社(米国)
- フィリップスN.V.( オランダ)
- iVascular S.L.U(スペイン)
- バイオセンサーズ・インターナショナル・グループ・リミテッド(シンガポール)
- BIOTRONIK (ドイツ)
- AMGインターナショナルGmbH（米国）
- ENDOCOR GmbH（ドイツ）
- メリル・ライフサイエンス社（Meril Life Sciences Pvt.(インド)
- アルビメディカ（トルコ）
- カーディオノバムGMBH（ドイツ）
- SMT（インド）
- メディノール社(イスラエル)
- Andramed GMBH（ドイツ）
- クック（米国）
- レックスメディカル（米国）
- デガニアシリコーン株式会社(イスラエル)
- ブロスメド・メディカル（中国）

研究範囲。
本レポートでは、製品別、地域別に末梢血管機器市場を調査しています。また、市場成長に影響を与える要因（促進要因、阻害要因、機会、課題など）を分析しています。利害関係者向けに市場の機会や課題を評価し、市場リーダー向けに競争環境の詳細を提供します。また、マイクロマーケットについては、その成長動向、展望、末梢血管機器市場全体への貢献度に関して調査しています。本レポートでは、5つの主要地域に関して、市場セグメントの収益を予測しています。


レポート購入の理由
本レポートは、以下のポイントに関する洞察を提供します。

- 市場の浸透度。末梢血管機器市場の上位25社が提供する末梢血管機器製品に関する包括的な情報。本レポートでは、末梢血管機器市場を製品別、地域別に分析しています。

- 市場の発展。有利な新興市場に関する包括的な情報。このレポートでは、主要な地域ごとの各種固定具の市場を分析しています。

- 市場の多様化。未開拓の地域、最近の開発、末梢血管機器市場への投資に関する徹底的な情報提供

- 競合の評価。末梢血管機器市場における主要企業の市場シェアと戦略に関する詳細な評価

ページTOPに戻る


目次

1 INTRODUCTION 49
1.1 OBJECTIVES OF THE STUDY 49
1.2 MARKET DEFINITION 49
1.3 MARKET SCOPE 50
1.3.1 MARKET SEGMENTATION 50
1.3.2 YEARS CONSIDERED FOR THE STUDY 51
1.4 CURRENCY 51
1.5 LIMITATIONS 51
1.6 STAKEHOLDERS 52
1.7 SUMMARY OF CHANGES 52
2 RESEARCH METHODOLOGY 53
2.1 RESEARCH DATA 53
FIGURE 1 RESEARCH DESIGNS 53
2.1.1 SECONDARY DATA 54
2.1.1.1 Key data from secondary sources 54
2.1.2 PRIMARY DATA 55
FIGURE 2 PRIMARY SOURCES 55
2.1.2.1 Key data from primary sources 56
2.1.2.2 Key industry insights 57
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 57
2.2 MARKET SIZE ESTIMATION 58
FIGURE 4 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH 58
2.2.1 GROWTH FORECAST 59
FIGURE 5 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 59
FIGURE 6 TOP-DOWN APPROACH 60
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 61
FIGURE 7 DATA TRIANGULATION METHODOLOGY 61
2.4 ASSUMPTIONS FOR THE STUDY 62
2.5 RISK ASSESSMENT 62
TABLE 1 RISKS 62
2.6 COVID-19 HEALTH ASSESSMENT 63
2.7 COVID-19 ECONOMIC ASSESSMENT 63
2.8 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO 63
FIGURE 9 RECOVERY SCENARIO OF THE GLOBAL ECONOMY 65
 
3 EXECUTIVE SUMMARY 66
FIGURE 10 ANGIOPLASTY STENTS MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION) 66
FIGURE 11 ENDOVASCULAR ANEURYSM REPAIR (EVAR) STENT GRAFTS MARKET,
BY TYPE, 2021 VS. 2026 (USD MILLION) 67
FIGURE 12 INFERIOR VENA CAVA (IVC) FILTERS MARKET, BY TYPE,
2021 VS. 2026 (USD MILLION) 67
FIGURE 13 CATHETERS MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION) 68
FIGURE 14 ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION) 68
FIGURE 15 PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2021 VS. 2026 (USD MILLION) 69
FIGURE 16 HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE,
2021 VS. 2026 (USD MILLION) 69
FIGURE 17 OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE,
2021 VS. 2026 (USD MILLION) 70
FIGURE 18 GEOGRAPHIC SNAPSHOT OF THE GLOBAL PERIPHERAL
VASCULAR DEVICES MARKET 71
4 PREMIUM INSIGHTS 72
4.1 PERIPHERAL VASCULAR DEVICES MARKET OVERVIEW 72
FIGURE 19 INCREASING PREVALENCE OF PERIPHERAL VASCULAR DISEASES TO DRIVE MARKET GROWTH DURING THE FORECAST PERIOD 72
4.2 PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE 72
FIGURE 20 DRUG-ELUTING STENT PRODUCTS TO ACCOUNT FOR THE LARGEST MARKET SHARE IN 2021 72
4.3 NORTH AMERICA: PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE OF ANGIOPLASTY STENT AND COUNTRY 73
FIGURE 21 THE US ACCOUNTED FOR THE LARGEST SHARE OF THE NORTH AMERICAN PERIPHERAL VASCULAR DEVICES MARKET IN 2021 73
4.4 PERIPHERAL VASCULAR DEVICES MARKET: GEOGRAPHIC SNAPSHOT 74
FIGURE 22 CHINA TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD 74
5 MARKET OVERVIEW 75
5.1 INTRODUCTION 75
5.2 MARKET DYNAMICS 75
FIGURE 23 PERIPHERAL VASCULAR DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 75
5.2.1 DRIVERS 76
5.2.1.1 Rapid growth in the geriatric population and the subsequent increase in the prevalence of peripheral vascular diseases 76
TABLE 2 GERIATRIC POPULATION, BY REGION, 2015 VS. 2030 76
5.2.1.2 Favorable reimbursement scenario for peripheral vascular procedures 76
TABLE 3 REIMBURSEMENT FOR PERIPHERAL VASCULAR PROCEDURES IN THE US 77
5.2.1.3 Increased number of product approvals 77
TABLE 4 PRODUCT APPROVALS IN THE PERIPHERAL VASCULAR DEVICES MARKET, 2017–2021 78
5.2.1.4 Increased prevalence of diabetes 78
TABLE 5 DIABETES POPULATION, BY REGION, 2019 VS. 2030 79
5.2.1.5 Rising rate of tobacco consumption 79
TABLE 6 THE TOP 10 COUNTRIES WITH THE HIGHEST SMOKING RATE (2021) 79
5.2.1.6 Growth in the incidence of obesity 80
TABLE 7 OBESITY RATE IN THE DEVELOPED COUNTRIES (2021) 80
5.2.2 RESTRAINTS 80
5.2.2.1 Increased number of product failures and recalls 80
5.2.3 OPPORTUNITIES 81
5.2.3.1 High growth rate in the emerging markets 81
5.2.4 CHALLENGES 81
5.2.4.1 Rise in the availability of alternative treatments 81
5.2.4.2 Dearth of skilled professionals with expertise in peripheral vascular devices 82
5.2.5 IMPACT OF THE COVID-19 PANDEMIC ON THE PERIPHERAL VASCULAR DEVICES MARKET 82
5.3 RANGES/SCENARIOS 83
5.3.1 PERIPHERAL VASCULAR DEVICES MARKET 83
FIGURE 24 PESSIMISTIC SCENARIO 83
FIGURE 25 OPTIMISTIC SCENARIO 83
FIGURE 26 REALISTIC SCENARIO 84
5.4 VALUE CHAIN ANALYSIS 84
FIGURE 27 MAJOR VALUE IS ADDED DURING THE MANUFACTURING AND ASSEMBLY PHASE 84
5.5 SUPPLY CHAIN ANALYSIS 85
FIGURE 28 DIRECT DISTRIBUTION—A STRATEGY PREFERRED BY PROMINENT COMPANIES 86
5.6 PORTER’S FIVE FORCES ANALYSIS 86
5.6.1 THREAT OF NEW ENTRANTS 86
5.6.2 INTENSITY OF COMPETITIVE RIVALRY 86
5.6.3 BARGAINING POWER OF BUYERS 87
5.6.4 BARGAINING POWER OF SUPPLIERS 87
5.6.5 THREAT OF SUBSTITUTES 87
5.7 TECHNOLOGY ANALYSIS 87
5.8 REGULATORY ANALYSIS 88
5.9 PATENT ANALYSIS 89
5.10 TRADE ANALYSIS 90
TABLE 8 IMPORT DATA FOR INSTRUMENTS AND APPLIANCES USED IN MEDICAL, SURGICAL, OR VETERINARY SERVICES, BY COUNTRY, 2016–2020 (USD MILLION) 90
TABLE 9 EXPORT DATA FOR INSTRUMENTS AND APPLIANCES USED IN MEDICAL, SURGICAL, OR VETERINARY SERVICES, BY COUNTRY, 2016–2020 (USD MILLION) 90
TABLE 10 IMPORT DATA FOR NEEDLES, CATHETERS, AND CANNULAE USED IN MEDICAL, SURGICAL, DENTAL, OR VETERINARY PROCEDURES, BY COUNTRY, 2016–2020 (USD MILLION) 91
TABLE 11 EXPORT DATA FOR NEEDLES, CATHETERS, AND CANNULAE USED IN MEDICAL, SURGICAL, DENTAL, OR VETERINARY PROCEDURES, BY COUNTRY, 2016–2020 (USD MILLION) 91
5.11 PRICING ANALYSIS 92
TABLE 12 PRICE RANGE FOR PERIPHERAL VASCULAR DEVICES 92
5.12 ECOSYSTEM MAPPING 92
5.12.1 ROLE IN ECOSYSTEM 93
FIGURE 29 KEY PLAYERS IN THE PERIPHERAL VASCULAR DEVICE ECOSYSTEM 93
5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 94
5.13.1 REVENUE SHIFT AND REVENUE POCKETS FOR PERIPHERAL VASCULAR DEVICES MARKET 94
5.13.2 REVENUE SHIFT FOR PERIPHERAL VASCULAR DEVICES 94
6 ANGIOPLASTY BALLOONS MARKET, BY TYPE 95
6.1 INTRODUCTION 96
TABLE 13 ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2016–2020 (USD MILLION) 96
TABLE 14 ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2021–2026 (USD MILLION) 96
TABLE 15 ANGIOPLASTY BALLOONS MARKET, BY REGION, 2016–2020 (USD MILLION) 97
TABLE 16 ANGIOPLASTY BALLOONS MARKET, BY REGION, 2021–2026 (USD MILLION) 97
6.2 OLD/NORMAL BALLOONS 97
6.2.1 OLD/NORMAL BALLOONS TO DOMINATE THE ANGIOPLASTY
BALLOONS MARKET 97
TABLE 17 OLD/NORMAL ANGIOPLASTY BALLOONS MARKET, BY REGION,
2016–2020 (USD MILLION) 98
TABLE 18 OLD/NORMAL ANGIOPLASTY BALLOONS MARKET, BY REGION,
2021–2026 (USD MILLION) 98
6.3 DRUG-ELUTING BALLOONS 98
6.3.1 DRUG-ELUTING BALLOONS TO WITNESS THE HIGHEST GROWTH IN THE ANGIOPLASTY BALLOONS MARKET 98
TABLE 19 DRUG-ELUTING BALLOONS MARKET, BY REGION,
2016–2020 (USD MILLION) 99
TABLE 20 DRUG-ELUTING BALLOONS MARKET, BY REGION,
2021–2026 (USD MILLION) 99
6.4 CUTTING AND SCORING BALLOONS 99
6.4.1 USE OF CUTTING BALLOONS IS LIMITED SINCE MEDICATION IS CONSIDERED THE PRIMARY TREATMENT FOR ATHEROSCLEROSIS 99
TABLE 21 CUTTING AND SCORING BALLOONS MARKET, BY REGION,
2016–2020 (USD MILLION) 100
TABLE 22 CUTTING AND SCORING BALLOONS MARKET, BY REGION,
2021–2026 (USD MILLION) 100
 
7 ANGIOPLASTY STENTS MARKET, BY TYPE 101
7.1 INTRODUCTION 102
TABLE 23 ANGIOPLASTY STENTS MARKET, BY TYPE, 2016–2020 (USD MILLION) 102
TABLE 24 ANGIOPLASTY STENTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 102
TABLE 25 ANGIOPLASTY STENTS MARKET, BY REGION, 2016–2020 (USD MILLION) 102
TABLE 26 ANGIOPLASTY STENTS MARKET, BY REGION, 2021–2026 (USD MILLION) 103
7.2 DRUG-ELUTING STENTS 103
7.2.1 DRUG-ELUTING STENTS TO WITNESS A HIGHER ADOPTION DUE TO THE REDUCED RESTENOSIS RATE 103
TABLE 27 DRUG-ELUTING STENTS MARKET, BY REGION, 2016–2020 (USD MILLION) 104
TABLE 28 DRUG-ELUTING STENTS MARKET, BY REGION, 2021–2026 (USD MILLION) 104
7.3 BARE-METAL STENTS 104
7.3.1 INCREASING USE OF DRUG-ELUTING STENTS TO RESTRAIN MARKET GROWTH 104
TABLE 29 BARE-METAL STENTS MARKET, BY REGION, 2016–2020 (USD MILLION) 105
TABLE 30 BARE-METAL STENTS MARKET, BY REGION, 2021–2026 (USD MILLION) 105
7.3.2 BARE-METAL STENTS, BY DELIVERY PLATFORM 105
TABLE 31 BARE-METAL STENTS MARKET, BY DELIVERY PLATFORM,
2016–2020 (USD MILLION) 105
TABLE 32 BARE-METAL STENTS MARKET, BY DELIVERY PLATFORM,
2021–2026 (USD MILLION) 106
7.3.2.1 Balloon-expandable stents 106
TABLE 33 BALLOON-EXPANDABLE STENTS MARKET, BY REGION,
2016–2020 (USD MILLION) 106
TABLE 34 BALLOON-EXPANDABLE STENTS MARKET, BY REGION,
2021–2026 (USD MILLION) 107
7.3.2.2 Self-expandable stents 107
TABLE 35 SELF-EXPANDABLE STENTS MARKET, BY REGION,
2016–2020 (USD MILLION) 107
TABLE 36 SELF-EXPANDABLE STENTS MARKET, BY REGION,
2021–2026 (USD MILLION) 108
8 CATHETERS MARKET, BY TYPE 109
8.1 INTRODUCTION 110
TABLE 37 CATHETERS MARKET, BY TYPE, 2016–2020 (USD MILLION) 110
TABLE 38 CATHETERS MARKET, BY TYPE, 2021–2026 (USD MILLION) 110
TABLE 39 CATHETERS MARKET, BY REGION, 2016–2020 (USD MILLION) 110
TABLE 40 CATHETERS MARKET, BY REGION, 2021–2026 (USD MILLION) 111
8.2 ANGIOGRAPHY CATHETERS 111
8.2.1 ANGIOGRAPHY CATHETERS TO DOMINATE THE CATHETERS MARKET 111
TABLE 41 ANGIOGRAPHY CATHETERS MARKET, BY REGION,
2016–2020 (USD MILLION) 112
TABLE 42 ANGIOGRAPHY CATHETERS MARKET, BY REGION,
2021–2026 (USD MILLION) 112
 
8.3 GUIDING CATHETERS 112
8.3.1 GUIDING CATHETERS TO ACCOUNT FOR THE SECOND-LARGEST SHARE OF THE CATHETERS MARKET 112
TABLE 43 GUIDING CATHETERS MARKET, BY REGION, 2016–2020 (USD MILLION) 113
TABLE 44 GUIDING CATHETERS MARKET, BY REGION, 2021–2026 (USD MILLION) 113
8.4 IVUS/OCT CATHETERS 113
8.4.1 IVUS/OCT CATHETERS SEGMENT TO REGISTER THE HIGHEST GROWTH RATE 113
TABLE 45 IVUS/OCT CATHETERS MARKET, BY REGION, 2016–2020 (USD MILLION) 114
TABLE 46 IVUS/OCT CATHETERS MARKET, BY REGION, 2021–2026 (USD MILLION) 114
9 ENDOVASCULAR ANEURYSM REPAIR STENT GRAFTS MARKET, BY TYPE 115
9.1 INTRODUCTION 116
TABLE 47 EVAR STENT GRAFTS MARKET, BY TYPE, 2016–2020 (USD MILLION) 116
TABLE 48 EVAR STENT GRAFTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 116
TABLE 49 EVAR STENT GRAFTS MARKET, BY REGION, 2016–2020 (USD MILLION) 116
TABLE 50 EVAR STENT GRAFTS MARKET, BY REGION, 2021–2026 (USD MILLION) 117
9.2 ABDOMINAL AORTIC ANEURYSM STENT GRAFTS 117
9.2.1 ABDOMINAL AORTIC ANEURYSM STENT GRAFTS TO DOMINATE THE MARKET 117
TABLE 51 ABDOMINAL AORTIC ANEURYSM STENT GRAFTS MARKET, BY REGION,
2016–2020 (USD MILLION) 118
TABLE 52 ABDOMINAL AORTIC ANEURYSM STENT GRAFTS MARKET, BY REGION,
2021–2026 (USD MILLION) 118
9.3 THORACIC AORTIC ANEURYSM STENT GRAFTS 118
9.3.1 INCREASING INCIDENCE OF THORACIC AORTIC ANEURYSMS TO DRIVE MARKET GROWTH IN THE COMING YEARS 118
TABLE 53 THORACIC AORTIC ANEURYSM STENT GRAFTS MARKET, BY REGION,
2016–2020 (USD MILLION) 119
TABLE 54 THORACIC AORTIC ANEURYSM STENT GRAFTS MARKET, BY REGION,
2021–2026 (USD MILLION) 119
10 INFERIOR VENA CAVA FILTERS MARKET, BY TYPE 120
10.1 INTRODUCTION 121
TABLE 55 INFERIOR VENA CAVA FILTERS MARKET, BY TYPE, 2016–2020 (USD MILLION) 121
TABLE 56 INFERIOR VENA CAVA FILTERS MARKET, BY TYPE, 2021–2026 (USD MILLION) 121
TABLE 57 INFERIOR VENA CAVA FILTERS MARKET, BY REGION,
2016–2020 (USD MILLION) 121
TABLE 58 INFERIOR VENA CAVA FILTERS MARKET, BY REGION,
2021–2026 (USD MILLION) 122
10.2 RETRIEVABLE FILTERS 122
10.2.1 RETRIEVABLE FILTERS SEGMENT TO REGISTER A HIGHER GROWTH RATE 122
TABLE 59 RETRIEVABLE INFERIOR VENA CAVA FILTERS MARKET, BY REGION,
2016–2020 (USD MILLION) 122
TABLE 60 RETRIEVABLE INFERIOR VENA CAVA FILTERS MARKET, BY REGION,
2021–2026 (USD MILLION) 123
 
10.3 PERMANENT FILTERS 123
10.3.1 RISKS ASSOCIATED WITH PERMANENT FILTERS TO HAMPER THEIR SALES DURING THE FORECAST PERIOD 123
TABLE 61 PERMANENT INFERIOR VENA CAVA FILTERS MARKET, BY REGION,
2016–2020 (USD MILLION) 123
TABLE 62 PERMANENT INFERIOR VENA CAVA FILTERS MARKET, BY REGION,
2021–2026 (USD MILLION) 124
11 PLAQUE MODIFICATION DEVICES MARKET, BY TYPE 125
11.1 INTRODUCTION 126
TABLE 63 PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2016–2020 (USD MILLION) 126
TABLE 64 PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2021–2026 (USD MILLION) 126
TABLE 65 PLAQUE MODIFICATION DEVICES MARKET, BY REGION,
2016–2020 (USD MILLION) 126
TABLE 66 PLAQUE MODIFICATION DEVICES MARKET, BY REGION,
2021–2026 (USD MILLION) 127
11.2 ATHERECTOMY DEVICES 127
11.2.1 INCREASING INCIDENCE OF ATHEROSCLEROSIS AS A RESULT OF THE RISING GLOBAL PREVALENCE OF OBESITY TO DRIVE THE MARKET 127
TABLE 67 ATHERECTOMY DEVICES MARKET, BY REGION, 2016–2020 (USD MILLION) 128
TABLE 68 ATHERECTOMY DEVICES MARKET, BY REGION, 2021–2026 (USD MILLION) 128
11.3 THROMBECTOMY DEVICES 128
11.3.1 GROWING DVT INCIDENCE TO DRIVE THE ADOPTION OF THROMBECTOMY DEVICES 128
TABLE 69 THROMBECTOMY DEVICES MARKET, BY REGION, 2016–2020 (USD MILLION) 129
TABLE 70 THROMBECTOMY DEVICES MARKET, BY REGION, 2021–2026 (USD MILLION) 129
12 HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE 130
12.1 INTRODUCTION 131
TABLE 71 HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE,
2016–2020 (USD MILLION) 131
TABLE 72 HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE,
2021–2026 (USD MILLION) 131
12.2 EMBOLIC PROTECTION DEVICES 131
12.2.1 INCREASING INVESTMENTS IN NEW TECHNOLOGY AND INCREASING REGULATORY APPROVALS TO DRIVE MARKET GROWTH 131
TABLE 73 EMBOLIC PROTECTION DEVICES MARKET, BY REGION,
2016–2020 (USD MILLION) 132
TABLE 74 EMBOLIC PROTECTION DEVICES MARKET, BY REGION,
2021–2026 (USD MILLION) 132
12.3 CHRONIC TOTAL OCCLUSION (CTO) DEVICES 133
12.3.1 INCREASING INVESTMENTS IN THE DEVELOPMENT OF CTO DEVICES TO DRIVE MARKET GROWTH 133
TABLE 75 CHRONIC TOTAL OCCLUSION DEVICES MARKET, BY REGION,
2016–2020 (USD MILLION) 133
TABLE 76 CHRONIC TOTAL OCCLUSION DEVICES MARKET, BY REGION,
2021–2026 (USD MILLION) 133
13 OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE 134
13.1 INTRODUCTION 135
TABLE 77 OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE,
2016–2020 (USD MILLION) 135
TABLE 78 OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE,
2021–2026 (USD MILLION) 135
TABLE 79 OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY REGION,
2016–2020 (USD MILLION) 136
TABLE 80 OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY REGION,
2021–2026 (USD MILLION) 136
13.2 GUIDEWIRES 136
TABLE 81 GUIDEWIRES MARKET, BY REGION, 2016–2020 (USD MILLION) 137
TABLE 82 GUIDEWIRES MARKET, BY REGION, 2021–2026 (USD MILLION) 137
13.3 VASCULAR CLOSURE DEVICES 137
TABLE 83 VASCULAR CLOSURE DEVICES MARKET, BY REGION,
2016–2020 (USD MILLION) 138
TABLE 84 VASCULAR CLOSURE DEVICES MARKET, BY REGION,
2021–2026 (USD MILLION) 138
13.4 INTRODUCER SHEATHS 138
TABLE 85 INTRODUCER SHEATHS MARKET, BY REGION, 2016–2020 (USD MILLION) 139
TABLE 86 INTRODUCER SHEATHS MARKET, BY REGION, 2021–2026 (USD MILLION) 139
13.5 BALLOON INFLATION DEVICES 139
TABLE 87 BALLOON INFLATION DEVICES MARKET, BY REGION,
2016–2020 (USD MILLION) 140
TABLE 88 BALLOON INFLATION DEVICES MARKET, BY REGION,
2021–2026 (USD MILLION) 140
14 PERIPHERAL VASCULAR DEVICES MARKET, BY REGION 141
14.1 INTRODUCTION 142
TABLE 89 PERIPHERAL VASCULAR DEVICES MARKET, BY REGION,
2016–2020 (USD MILLION) 142
TABLE 90 PERIPHERAL VASCULAR DEVICES MARKET, BY REGION,
2021–2026 (USD MILLION) 142
14.2 NORTH AMERICA 143
FIGURE 30 NORTH AMERICA: MARKET SNAPSHOT 143
TABLE 91 NORTH AMERICA: PERIPHERAL VASCULAR DEVICES MARKET, BY COUNTRY, 2016–2020 (USD MILLION) 144
TABLE 92 NORTH AMERICA: PERIPHERAL VASCULAR DEVICES MARKET, BY COUNTRY, 2021–2026 (USD MILLION) 144
TABLE 93 NORTH AMERICA: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2016–2020 (USD MILLION) 144
TABLE 94 NORTH AMERICA: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2021–2026 (USD MILLION) 145
TABLE 95 NORTH AMERICA: ANGIOPLASTY STENTS MARKET, BY TYPE,
2016–2020 (USD MILLION) 145
TABLE 96 NORTH AMERICA: ANGIOPLASTY STENTS MARKET, BY TYPE,
2021–2026 (USD MILLION) 145
TABLE 97 NORTH AMERICA: CATHETERS MARKET, BY TYPE, 2016–2020 (USD MILLION) 146
TABLE 98 NORTH AMERICA: CATHETERS MARKET, BY TYPE, 2021–2026 (USD MILLION) 146
TABLE 99 NORTH AMERICA: EVAR STENT GRAFTS MARKET, BY TYPE,
2016–2020 (USD MILLION) 146
TABLE 100 NORTH AMERICA: EVAR STENT GRAFTS MARKET, BY TYPE,
2021–2026 (USD MILLION) 147
TABLE 101 NORTH AMERICA: IVC FILTERS MARKET, BY TYPE, 2016–2020 (USD MILLION) 147
TABLE 102 NORTH AMERICA: IVC FILTERS MARKET, BY TYPE, 2021–2026 (USD MILLION) 147
TABLE 103 NORTH AMERICA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2016–2020 (USD MILLION) 147
TABLE 104 NORTH AMERICA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2021–2026 (USD MILLION) 148
TABLE 105 NORTH AMERICA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET,
BY TYPE, 2016–2020 (USD MILLION) 148
TABLE 106 NORTH AMERICA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET,
BY TYPE, 2021–2026 (USD MILLION) 148
TABLE 107 NORTH AMERICA: OTHER PERIPHERAL VASCULAR DEVICES MARKET,
BY TYPE, 2016–2020 (USD MILLION) 149
TABLE 108 NORTH AMERICA: OTHER PERIPHERAL VASCULAR DEVICES MARKET,
BY TYPE, 2021–2026 (USD MILLION) 149
14.2.1 FAVORABLE REIMBURSEMENT SCENARIO TO ENSURE DEVICE
ADOPTION IN THE US 149
TABLE 109 US: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2016–2020 (USD MILLION) 151
TABLE 110 US: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2021–2026 (USD MILLION) 151
TABLE 111 US: ANGIOPLASTY STENTS MARKET, BY TYPE, 2016–2020 (USD MILLION) 151
TABLE 112 US: ANGIOPLASTY STENTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 152
TABLE 113 US: CATHETERS MARKET, BY TYPE, 2016–2020 (USD MILLION) 152
TABLE 114 US: CATHETERS MARKET, BY TYPE, 2021–2026 (USD MILLION) 152
TABLE 115 US: EVAR STENT GRAFTS MARKET, BY TYPE, 2016–2020 (USD MILLION) 153
TABLE 116 US: EVAR STENT GRAFTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 153
TABLE 117 US: IVC FILTERS MARKET, BY TYPE, 2016–2020 (USD MILLION) 153
TABLE 118 US: IVC FILTERS MARKET, BY TYPE, 2021–2026 (USD MILLION) 153
TABLE 119 US: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2016–2020 (USD MILLION) 154
TABLE 120 US: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2021–2026 (USD MILLION) 154
TABLE 121 US: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE,
2016–2020 (USD MILLION) 154
TABLE 122 US: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE,
2021–2026 (USD MILLION) 155
TABLE 123 US: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE,
2016–2020 (USD MILLION) 155
TABLE 124 US: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE,
2021–2026 (USD MILLION) 155
14.2.2 CANADA 156
14.2.2.1 Rising prevalence of target diseases to drive market growth 156
TABLE 125 CANADA: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2016–2020 (USD MILLION) 156
TABLE 126 CANADA: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2021–2026 (USD MILLION) 156
TABLE 127 CANADA: ANGIOPLASTY STENTS MARKET, BY TYPE,
2016–2020 (USD MILLION) 157
TABLE 128 CANADA: ANGIOPLASTY STENTS MARKET, BY TYPE,
2021–2026 (USD MILLION) 157
TABLE 129 CANADA: CATHETERS MARKET, BY TYPE, 2016–2020 (USD MILLION) 157
TABLE 130 CANADA: CATHETERS MARKET, BY TYPE, 2021–2026 (USD MILLION) 158
TABLE 131 CANADA: EVAR STENT GRAFTS MARKET, BY TYPE,
2016–2020 (USD MILLION) 158
TABLE 132 CANADA: EVAR STENT GRAFTS MARKET, BY TYPE,
2021–2026 (USD MILLION) 158
TABLE 133 CANADA: IVC FILTERS MARKET, BY TYPE, 2016–2020 (USD MILLION) 159
TABLE 134 CANADA: IVC FILTERS MARKET, BY TYPE, 2021–2026 (USD MILLION) 159
TABLE 135 CANADA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2016–2020 (USD MILLION) 159
TABLE 136 CANADA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2021–2026 (USD MILLION) 160
TABLE 137 CANADA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2016–2020 (USD MILLION) 160
TABLE 138 CANADA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2021–2026 (USD MILLION) 160
TABLE 139 CANADA: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE,
2016–2020 (USD MILLION) 161
TABLE 140 CANADA: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE,
2021–2026 (USD MILLION) 161
14.3 EUROPE 161
TABLE 141 EUROPE: PERIPHERAL VASCULAR DEVICES MARKET, BY COUNTRY,
2016–2020 (USD MILLION) 162
TABLE 142 EUROPE: PERIPHERAL VASCULAR DEVICES MARKET, BY COUNTRY,
2021–2026 (USD MILLION) 162
TABLE 143 EUROPE: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2016–2020 (USD MILLION) 163
TABLE 144 EUROPE: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2021–2026 (USD MILLION) 163
TABLE 145 EUROPE: ANGIOPLASTY STENTS MARKET, BY TYPE,
2016–2020 (USD MILLION) 163
TABLE 146 EUROPE: ANGIOPLASTY STENTS MARKET, BY TYPE,
2021–2026 (USD MILLION) 163
TABLE 147 EUROPE: CATHETERS MARKET, BY TYPE, 2016–2020 (USD MILLION) 164
TABLE 148 EUROPE: CATHETERS MARKET, BY TYPE, 2021–2026 (USD MILLION) 164
TABLE 149 EUROPE: EVAR STENT GRAFTS MARKET, BY TYPE, 2016–2020 (USD MILLION) 164
TABLE 150 EUROPE: EVAR STENT GRAFTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 164
TABLE 151 EUROPE: IVC FILTERS MARKET, BY TYPE, 2016–2020 (USD MILLION) 165
TABLE 152 EUROPE: IVC FILTERS MARKET, BY TYPE, 2021–2026 (USD MILLION) 165
TABLE 153 EUROPE: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2016–2020 (USD MILLION) 165
TABLE 154 EUROPE: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2021–2026 (USD MILLION) 165
TABLE 155 EUROPE: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2016–2020 (USD MILLION) 166
TABLE 156 EUROPE: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2021–2026 (USD MILLION) 166
TABLE 157 EUROPE: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE,
2016–2020 (USD MILLION) 166
TABLE 158 EUROPE: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE,
2021–2026 (USD MILLION) 167
14.3.1 GERMANY 167
14.3.1.1 Increase in geriatric and obese populations contribute to device demand 167
TABLE 159 GERMANY: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2016–2020 (USD MILLION) 168
TABLE 160 GERMANY: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2021–2026 (USD MILLION) 168
TABLE 161 GERMANY: ANGIOPLASTY STENTS MARKET, BY TYPE,
2016–2020 (USD MILLION) 168
TABLE 162 GERMANY: ANGIOPLASTY STENTS MARKET, BY TYPE,
2021–2026 (USD MILLION) 168
TABLE 163 GERMANY: CATHETERS MARKET, BY TYPE, 2016–2020 (USD MILLION) 169
TABLE 164 GERMANY: CATHETERS MARKET, BY TYPE, 2021–2026 (USD MILLION) 169
TABLE 165 GERMANY: EVAR STENT GRAFTS MARKET, BY TYPE,
2016–2020 (USD MILLION) 169
TABLE 166 GERMANY: EVAR STENT GRAFTS MARKET, BY TYPE,
2021–2026 (USD MILLION) 169
TABLE 167 GERMANY: IVC FILTERS MARKET, BY TYPE, 2016–2020 (USD MILLION) 170
TABLE 168 GERMANY: IVC FILTERS MARKET, BY TYPE, 2021–2026 (USD MILLION) 170
TABLE 169 GERMANY: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2016–2020 (USD MILLION) 170
TABLE 170 GERMANY: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2021–2026 (USD MILLION) 170
TABLE 171 GERMANY: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2016–2020 (USD MILLION) 171
TABLE 172 GERMANY: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2021–2026 (USD MILLION) 171
TABLE 173 GERMANY: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2016–2020 (USD MILLION) 171
TABLE 174 GERMANY: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2021–2026 (USD MILLION) 172
14.3.2 FRANCE 172
14.3.2.1 Incidence of PE and DVT to increase owing to the growth of France’s geriatric population 172
TABLE 175 FRANCE: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2016–2020 (USD MILLION) 173
TABLE 176 FRANCE: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2021–2026 (USD MILLION) 173
TABLE 177 FRANCE: ANGIOPLASTY STENTS MARKET, BY TYPE,
2016–2020 (USD MILLION) 173
TABLE 178 FRANCE: ANGIOPLASTY STENTS MARKET, BY TYPE,
2021–2026 (USD MILLION) 173
TABLE 179 FRANCE: CATHETERS MARKET, BY TYPE, 2016–2020 (USD MILLION) 174
TABLE 180 FRANCE: CATHETERS MARKET, BY TYPE, 2021–2026 (USD MILLION) 174
TABLE 181 FRANCE: EVAR STENT GRAFTS MARKET, BY TYPE, 2016–2020 (USD MILLION) 174
TABLE 182 FRANCE: EVAR STENT GRAFTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 174
TABLE 183 FRANCE: IVC FILTERS MARKET, BY TYPE, 2016–2020 (USD MILLION) 175
TABLE 184 FRANCE: IVC FILTERS MARKET, BY TYPE, 2021–2026 (USD MILLION) 175
TABLE 185 FRANCE: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2016–2020 (USD MILLION) 175
TABLE 186 FRANCE: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2021–2026 (USD MILLION) 175
TABLE 187 FRANCE: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2016–2020 (USD MILLION) 176
TABLE 188 FRANCE: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2021–2026 (USD MILLION) 176
TABLE 189 FRANCE: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE,
2016–2020 (USD MILLION) 176
TABLE 190 FRANCE: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE,
2021–2026 (USD MILLION) 177
14.3.3 UK 177
14.3.3.1 Increasing incidence of peripheral vascular diseases to support market growth in the UK 177
TABLE 191 UK: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2016–2020 (USD MILLION) 178
TABLE 192 UK: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2021–2026 (USD MILLION) 178
TABLE 193 UK: ANGIOPLASTY STENTS MARKET, BY TYPE, 2016–2020 (USD MILLION) 178
TABLE 194 UK: ANGIOPLASTY STENTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 179
TABLE 195 UK: CATHETERS MARKET, BY TYPE, 2016–2020 (USD MILLION) 179
TABLE 196 UK: CATHETERS MARKET, BY TYPE, 2021–2026 (USD MILLION) 179
TABLE 197 UK: EVAR STENT GRAFTS MARKET, BY TYPE, 2016–2020 (USD MILLION) 179
TABLE 198 UK: EVAR STENT GRAFTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 180
TABLE 199 UK: IVC FILTERS MARKET, BY TYPE, 2016–2020 (USD MILLION) 180
TABLE 200 UK: IVC FILTERS MARKET, BY TYPE, 2021–2026 (USD MILLION) 180
TABLE 201 UK: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2016–2020 (USD MILLION) 180
TABLE 202 UK: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2021–2026 (USD MILLION) 181
TABLE 203 UK: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE,
2016–2020 (USD MILLION) 181
TABLE 204 UK: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE,
2021–2026 (USD MILLION) 181
TABLE 205 UK: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE,
2016–2020 (USD MILLION) 182
TABLE 206 UK: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE,
2021–2026 (USD MILLION) 182
14.3.4 SPAIN 182
14.3.4.1 Rising geriatric population to increase the demand for peripheral vascular devices 182
TABLE 207 SPAIN: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2016–2020 (USD MILLION) 183
TABLE 208 SPAIN: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2021–2026 (USD MILLION) 183
TABLE 209 SPAIN: ANGIOPLASTY STENTS MARKET, BY TYPE, 2016–2020 (USD MILLION) 183
TABLE 210 SPAIN: ANGIOPLASTY STENTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 184
TABLE 211 SPAIN: CATHETERS MARKET, BY TYPE, 2016–2020 (USD MILLION) 184
TABLE 212 SPAIN: CATHETERS MARKET, BY TYPE, 2021–2026 (USD MILLION) 184
TABLE 213 SPAIN: EVAR STENT GRAFTS MARKET, BY TYPE, 2016–2020 (USD MILLION) 184
TABLE 214 SPAIN: EVAR STENT GRAFTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 185
TABLE 215 SPAIN: IVC FILTERS MARKET, BY TYPE, 2016–2020 (USD MILLION) 185
TABLE 216 SPAIN: IVC FILTERS MARKET, BY TYPE, 2021–2026 (USD MILLION) 185
TABLE 217 SPAIN: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2016–2020 (USD MILLION) 185
TABLE 218 SPAIN: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2021–2026 (USD MILLION) 186
TABLE 219 SPAIN: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2016–2020 (USD MILLION) 186
TABLE 220 SPAIN: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2021–2026 (USD MILLION) 186
TABLE 221 SPAIN: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE,
2016–2020 (USD MILLION) 187
TABLE 222 SPAIN: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE,
2021–2026 (USD MILLION) 187
14.3.5 ITALY 187
14.3.5.1 Increasing health expenditure and rising diabetes prevalence to drive market growth 187
TABLE 223 ITALY: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2016–2020 (USD MILLION) 188
TABLE 224 ITALY: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2021–2026 (USD MILLION) 188
TABLE 225 ITALY: ANGIOPLASTY STENTS MARKET, BY TYPE, 2016–2020 (USD MILLION) 188
TABLE 226 ITALY: ANGIOPLASTY STENTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 189
TABLE 227 ITALY: CATHETERS MARKET, BY TYPE, 2016–2020 (USD MILLION) 189
TABLE 228 ITALY: CATHETERS MARKET, BY TYPE, 2021–2026 (USD MILLION) 189
TABLE 229 ITALY: EVAR STENT GRAFTS MARKET, BY TYPE, 2016–2020 (USD MILLION) 189
TABLE 230 ITALY: EVAR STENT GRAFTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 190
TABLE 231 ITALY: IVC FILTERS MARKET, BY TYPE, 2016–2020 (USD MILLION) 190
TABLE 232 ITALY: IVC FILTERS MARKET, BY TYPE, 2021–2026 (USD MILLION) 190
TABLE 233 ITALY: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2016–2020 (USD MILLION) 190
TABLE 234 ITALY: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2021–2026 (USD MILLION) 191
TABLE 235 ITALY: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE,
2016–2020 (USD MILLION) 191
TABLE 236 ITALY: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE,
2021–2026 (USD MILLION) 191
TABLE 237 ITALY: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE,
2016–2020 (USD MILLION) 192
TABLE 238 ITALY: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE,
2021–2026 (USD MILLION) 192
14.3.6 REST OF EUROPE 192
TABLE 239 ROE: HEALTHCARE EXPENDITURE, BY COUNTRY, 2010 VS. 2018 (% OF GDP) 193
TABLE 240 ROE: PERCENTAGE OF GERIATRIC POPULATION TO THE TOTAL POPULATION, BY COUNTRY, 2015 VS. 2030 (MILLION) 193
TABLE 241 ROE: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2016–2020 (USD MILLION) 194
TABLE 242 ROE: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2021–2026 (USD MILLION) 194
TABLE 243 ROE: ANGIOPLASTY STENTS MARKET, BY TYPE, 2016–2020 (USD MILLION) 194
TABLE 244 ROE: ANGIOPLASTY STENTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 194
TABLE 245 ROE: CATHETERS MARKET, BY TYPE, 2016–2020 (USD MILLION) 195
TABLE 246 ROE: CATHETERS MARKET, BY TYPE, 2021–2026 (USD MILLION) 195
TABLE 247 ROE: EVAR STENT GRAFTS MARKET, BY TYPE, 2016–2020 (USD MILLION) 195
TABLE 248 ROE: EVAR STENT GRAFTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 196
TABLE 249 ROE: IVC FILTERS MARKET, BY TYPE, 2016–2020 (USD MILLION) 196
TABLE 250 ROE: IVC FILTERS MARKET, BY TYPE, 2021–2026 (USD MILLION) 196
TABLE 251 ROE: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2016–2020 (USD MILLION) 196
TABLE 252 ROE: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2021–2026 (USD MILLION) 197
TABLE 253 ROE: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE,
2016–2020 (USD MILLION) 197
TABLE 254 ROE: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE,
2021–2026 (USD MILLION) 197
TABLE 255 ROE: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE,
2016–2020 (USD MILLION) 198
TABLE 256 ROE: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE,
2021–2026 (USD MILLION) 198

　

ページTOPに戻る


　

Summary

The global peripheral vascular devices market size is projected to reach USD 13.4billion by 2026 from USD 10.3billion in 2021, at a CAGR of 5.3% from 2021 to 2026. The growth of this market is driven by rapid growth in the geriatric population and the subsequent increase in the prevalence of peripheral vascular diseases, favorable reimbursement scenario for peripheral vascular procedures, Increased number of product approvals, increased prevalence of diabetes, and rising rate of tobacco consumption.
“Hemodynamic flow alteration devices in the product segment to witness the highest growth during the forecast period.”
Based on the product, the peripheral vascular devices market is segmented into angioplasty balloon, angioplasty stent, catheters, endovascular aneurysm repair stent grafts, inferior vena cava filters, plaque modification devices, hemodynamic flow alteration devices, other peripheral vascular devices. The Embolic Protection Devices segment is projected to grow at the highest CAGR during the forecast period. The major factors contributing to the growth of this market are increasing investments in new technology development and the growing number of regulatory approvals for these devices, and venture capital funding for the development of advanced EPDs.

“Asia Pacific is estimated to register the highest CAGR during the forecast period.”
In this report, the peripheral vascular devices market is segmented into four major regional segments, namely, North America, Europe, Asia Pacific, and the Rest of the World (RoW). The market in Asia Pacificisprojected to register the highest growth rate during the forecast period. The growth in this market is primarily driven by the rising geriatric population, increasing awareness among surgeons about the benefits of minimally invasive surgeries, and the rising patient population base for target diseases in several APAC countries.

Breakdown of supply-side primary interviews, by company type, designation, and region:

• By Company Type: Tier 1 (32%), Tier 2(44%), and Tier 3 (24%)

• By Designation: C-level (30%), Director-level (34%), and Others (36%)

• By Region: North America (40%), Europe (28%), AsiaPacific(20%), and Rest of the World(12%)


List of Companies Profiled in the Report

• Medtronic (Ireland)
• Boston Scientific Corporation (US)
• Abbott (US)
• Becton, Dickinson and Company (US)
• Terumo Corporation (Japan)
• Cardinal Health (US)
• B. Braun Melsungen AG (US)
• Merit Medical Systems (US)
• Penumbra, Inc.(US)
• Koninklijke Philips N.V.( Netherlands)
• iVascular S.L.U (Spain)
• Biosensors International Group Ltd. (Singapore)
• BIOTRONIK (Germany)
• AMG International GmbH (US)
• ENDOCOR GmbH (Germany)
• Meril Life Sciences Pvt. Ltd. (India)
• Alvimedica (Turkey)
• Cardionovum GMBH (Germany)
• SMT (India)
• Medinol Ltd. (Israel)
• Andramed GMBH (Germany)
• Cook (US)
• Rex Medical (US)
• Degania Silicone Ltd. (Israel)
• BrosMed Medical (China)

Research Coverage:
This report studies the peripheral vascular devicesmarket based on product,and region. The report also analyzes factors (such as drivers, restraints, opportunities, and challenges) affecting the market growth. It evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarketswith respect to their growth trends, prospects, and contributions to the total peripheral vascular devices market. The report forecasts the revenue of the market segments with respect to five major regions.


Reasons to Buy the Report:
The report provides insights on the following pointers:

• Market Penetration: Comprehensive information on peripheral vascular devices productsoffered by the top 25players in the peripheral vascular devices market. The reportanalyzes theperipheral vascular devices market by product,and region.

• Market Development: Comprehensive information about lucrative emerging markets. The report analyzes the markets for various securement devicesacross key geographic regions.

• Market Diversification: Exhaustive information about untapped geographies, recent developments, and investments in the peripheral vascular devices market

• Competitive Assessment: In-depth assessment of market shares and strategies of the leading players in the peripheral vascular devices market



ページTOPに戻る


Table of Contents

1 INTRODUCTION 49
1.1 OBJECTIVES OF THE STUDY 49
1.2 MARKET DEFINITION 49
1.3 MARKET SCOPE 50
1.3.1 MARKET SEGMENTATION 50
1.3.2 YEARS CONSIDERED FOR THE STUDY 51
1.4 CURRENCY 51
1.5 LIMITATIONS 51
1.6 STAKEHOLDERS 52
1.7 SUMMARY OF CHANGES 52
2 RESEARCH METHODOLOGY 53
2.1 RESEARCH DATA 53
FIGURE 1 RESEARCH DESIGNS 53
2.1.1 SECONDARY DATA 54
2.1.1.1 Key data from secondary sources 54
2.1.2 PRIMARY DATA 55
FIGURE 2 PRIMARY SOURCES 55
2.1.2.1 Key data from primary sources 56
2.1.2.2 Key industry insights 57
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION 57
2.2 MARKET SIZE ESTIMATION 58
FIGURE 4 MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH 58
2.2.1 GROWTH FORECAST 59
FIGURE 5 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 59
FIGURE 6 TOP-DOWN APPROACH 60
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 61
FIGURE 7 DATA TRIANGULATION METHODOLOGY 61
2.4 ASSUMPTIONS FOR THE STUDY 62
2.5 RISK ASSESSMENT 62
TABLE 1 RISKS 62
2.6 COVID-19 HEALTH ASSESSMENT 63
2.7 COVID-19 ECONOMIC ASSESSMENT 63
2.8 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO 63
FIGURE 9 RECOVERY SCENARIO OF THE GLOBAL ECONOMY 65
 
3 EXECUTIVE SUMMARY 66
FIGURE 10 ANGIOPLASTY STENTS MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION) 66
FIGURE 11 ENDOVASCULAR ANEURYSM REPAIR (EVAR) STENT GRAFTS MARKET,
BY TYPE, 2021 VS. 2026 (USD MILLION) 67
FIGURE 12 INFERIOR VENA CAVA (IVC) FILTERS MARKET, BY TYPE,
2021 VS. 2026 (USD MILLION) 67
FIGURE 13 CATHETERS MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION) 68
FIGURE 14 ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2021 VS. 2026 (USD MILLION) 68
FIGURE 15 PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2021 VS. 2026 (USD MILLION) 69
FIGURE 16 HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE,
2021 VS. 2026 (USD MILLION) 69
FIGURE 17 OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE,
2021 VS. 2026 (USD MILLION) 70
FIGURE 18 GEOGRAPHIC SNAPSHOT OF THE GLOBAL PERIPHERAL
VASCULAR DEVICES MARKET 71
4 PREMIUM INSIGHTS 72
4.1 PERIPHERAL VASCULAR DEVICES MARKET OVERVIEW 72
FIGURE 19 INCREASING PREVALENCE OF PERIPHERAL VASCULAR DISEASES TO DRIVE MARKET GROWTH DURING THE FORECAST PERIOD 72
4.2 PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE 72
FIGURE 20 DRUG-ELUTING STENT PRODUCTS TO ACCOUNT FOR THE LARGEST MARKET SHARE IN 2021 72
4.3 NORTH AMERICA: PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE OF ANGIOPLASTY STENT AND COUNTRY 73
FIGURE 21 THE US ACCOUNTED FOR THE LARGEST SHARE OF THE NORTH AMERICAN PERIPHERAL VASCULAR DEVICES MARKET IN 2021 73
4.4 PERIPHERAL VASCULAR DEVICES MARKET: GEOGRAPHIC SNAPSHOT 74
FIGURE 22 CHINA TO REGISTER THE HIGHEST GROWTH DURING THE FORECAST PERIOD 74
5 MARKET OVERVIEW 75
5.1 INTRODUCTION 75
5.2 MARKET DYNAMICS 75
FIGURE 23 PERIPHERAL VASCULAR DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 75
5.2.1 DRIVERS 76
5.2.1.1 Rapid growth in the geriatric population and the subsequent increase in the prevalence of peripheral vascular diseases 76
TABLE 2 GERIATRIC POPULATION, BY REGION, 2015 VS. 2030 76
5.2.1.2 Favorable reimbursement scenario for peripheral vascular procedures 76
TABLE 3 REIMBURSEMENT FOR PERIPHERAL VASCULAR PROCEDURES IN THE US 77
5.2.1.3 Increased number of product approvals 77
TABLE 4 PRODUCT APPROVALS IN THE PERIPHERAL VASCULAR DEVICES MARKET, 2017–2021 78
5.2.1.4 Increased prevalence of diabetes 78
TABLE 5 DIABETES POPULATION, BY REGION, 2019 VS. 2030 79
5.2.1.5 Rising rate of tobacco consumption 79
TABLE 6 THE TOP 10 COUNTRIES WITH THE HIGHEST SMOKING RATE (2021) 79
5.2.1.6 Growth in the incidence of obesity 80
TABLE 7 OBESITY RATE IN THE DEVELOPED COUNTRIES (2021) 80
5.2.2 RESTRAINTS 80
5.2.2.1 Increased number of product failures and recalls 80
5.2.3 OPPORTUNITIES 81
5.2.3.1 High growth rate in the emerging markets 81
5.2.4 CHALLENGES 81
5.2.4.1 Rise in the availability of alternative treatments 81
5.2.4.2 Dearth of skilled professionals with expertise in peripheral vascular devices 82
5.2.5 IMPACT OF THE COVID-19 PANDEMIC ON THE PERIPHERAL VASCULAR DEVICES MARKET 82
5.3 RANGES/SCENARIOS 83
5.3.1 PERIPHERAL VASCULAR DEVICES MARKET 83
FIGURE 24 PESSIMISTIC SCENARIO 83
FIGURE 25 OPTIMISTIC SCENARIO 83
FIGURE 26 REALISTIC SCENARIO 84
5.4 VALUE CHAIN ANALYSIS 84
FIGURE 27 MAJOR VALUE IS ADDED DURING THE MANUFACTURING AND ASSEMBLY PHASE 84
5.5 SUPPLY CHAIN ANALYSIS 85
FIGURE 28 DIRECT DISTRIBUTION—A STRATEGY PREFERRED BY PROMINENT COMPANIES 86
5.6 PORTER’S FIVE FORCES ANALYSIS 86
5.6.1 THREAT OF NEW ENTRANTS 86
5.6.2 INTENSITY OF COMPETITIVE RIVALRY 86
5.6.3 BARGAINING POWER OF BUYERS 87
5.6.4 BARGAINING POWER OF SUPPLIERS 87
5.6.5 THREAT OF SUBSTITUTES 87
5.7 TECHNOLOGY ANALYSIS 87
5.8 REGULATORY ANALYSIS 88
5.9 PATENT ANALYSIS 89
5.10 TRADE ANALYSIS 90
TABLE 8 IMPORT DATA FOR INSTRUMENTS AND APPLIANCES USED IN MEDICAL, SURGICAL, OR VETERINARY SERVICES, BY COUNTRY, 2016–2020 (USD MILLION) 90
TABLE 9 EXPORT DATA FOR INSTRUMENTS AND APPLIANCES USED IN MEDICAL, SURGICAL, OR VETERINARY SERVICES, BY COUNTRY, 2016–2020 (USD MILLION) 90
TABLE 10 IMPORT DATA FOR NEEDLES, CATHETERS, AND CANNULAE USED IN MEDICAL, SURGICAL, DENTAL, OR VETERINARY PROCEDURES, BY COUNTRY, 2016–2020 (USD MILLION) 91
TABLE 11 EXPORT DATA FOR NEEDLES, CATHETERS, AND CANNULAE USED IN MEDICAL, SURGICAL, DENTAL, OR VETERINARY PROCEDURES, BY COUNTRY, 2016–2020 (USD MILLION) 91
5.11 PRICING ANALYSIS 92
TABLE 12 PRICE RANGE FOR PERIPHERAL VASCULAR DEVICES 92
5.12 ECOSYSTEM MAPPING 92
5.12.1 ROLE IN ECOSYSTEM 93
FIGURE 29 KEY PLAYERS IN THE PERIPHERAL VASCULAR DEVICE ECOSYSTEM 93
5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 94
5.13.1 REVENUE SHIFT AND REVENUE POCKETS FOR PERIPHERAL VASCULAR DEVICES MARKET 94
5.13.2 REVENUE SHIFT FOR PERIPHERAL VASCULAR DEVICES 94
6 ANGIOPLASTY BALLOONS MARKET, BY TYPE 95
6.1 INTRODUCTION 96
TABLE 13 ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2016–2020 (USD MILLION) 96
TABLE 14 ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2021–2026 (USD MILLION) 96
TABLE 15 ANGIOPLASTY BALLOONS MARKET, BY REGION, 2016–2020 (USD MILLION) 97
TABLE 16 ANGIOPLASTY BALLOONS MARKET, BY REGION, 2021–2026 (USD MILLION) 97
6.2 OLD/NORMAL BALLOONS 97
6.2.1 OLD/NORMAL BALLOONS TO DOMINATE THE ANGIOPLASTY
BALLOONS MARKET 97
TABLE 17 OLD/NORMAL ANGIOPLASTY BALLOONS MARKET, BY REGION,
2016–2020 (USD MILLION) 98
TABLE 18 OLD/NORMAL ANGIOPLASTY BALLOONS MARKET, BY REGION,
2021–2026 (USD MILLION) 98
6.3 DRUG-ELUTING BALLOONS 98
6.3.1 DRUG-ELUTING BALLOONS TO WITNESS THE HIGHEST GROWTH IN THE ANGIOPLASTY BALLOONS MARKET 98
TABLE 19 DRUG-ELUTING BALLOONS MARKET, BY REGION,
2016–2020 (USD MILLION) 99
TABLE 20 DRUG-ELUTING BALLOONS MARKET, BY REGION,
2021–2026 (USD MILLION) 99
6.4 CUTTING AND SCORING BALLOONS 99
6.4.1 USE OF CUTTING BALLOONS IS LIMITED SINCE MEDICATION IS CONSIDERED THE PRIMARY TREATMENT FOR ATHEROSCLEROSIS 99
TABLE 21 CUTTING AND SCORING BALLOONS MARKET, BY REGION,
2016–2020 (USD MILLION) 100
TABLE 22 CUTTING AND SCORING BALLOONS MARKET, BY REGION,
2021–2026 (USD MILLION) 100
 
7 ANGIOPLASTY STENTS MARKET, BY TYPE 101
7.1 INTRODUCTION 102
TABLE 23 ANGIOPLASTY STENTS MARKET, BY TYPE, 2016–2020 (USD MILLION) 102
TABLE 24 ANGIOPLASTY STENTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 102
TABLE 25 ANGIOPLASTY STENTS MARKET, BY REGION, 2016–2020 (USD MILLION) 102
TABLE 26 ANGIOPLASTY STENTS MARKET, BY REGION, 2021–2026 (USD MILLION) 103
7.2 DRUG-ELUTING STENTS 103
7.2.1 DRUG-ELUTING STENTS TO WITNESS A HIGHER ADOPTION DUE TO THE REDUCED RESTENOSIS RATE 103
TABLE 27 DRUG-ELUTING STENTS MARKET, BY REGION, 2016–2020 (USD MILLION) 104
TABLE 28 DRUG-ELUTING STENTS MARKET, BY REGION, 2021–2026 (USD MILLION) 104
7.3 BARE-METAL STENTS 104
7.3.1 INCREASING USE OF DRUG-ELUTING STENTS TO RESTRAIN MARKET GROWTH 104
TABLE 29 BARE-METAL STENTS MARKET, BY REGION, 2016–2020 (USD MILLION) 105
TABLE 30 BARE-METAL STENTS MARKET, BY REGION, 2021–2026 (USD MILLION) 105
7.3.2 BARE-METAL STENTS, BY DELIVERY PLATFORM 105
TABLE 31 BARE-METAL STENTS MARKET, BY DELIVERY PLATFORM,
2016–2020 (USD MILLION) 105
TABLE 32 BARE-METAL STENTS MARKET, BY DELIVERY PLATFORM,
2021–2026 (USD MILLION) 106
7.3.2.1 Balloon-expandable stents 106
TABLE 33 BALLOON-EXPANDABLE STENTS MARKET, BY REGION,
2016–2020 (USD MILLION) 106
TABLE 34 BALLOON-EXPANDABLE STENTS MARKET, BY REGION,
2021–2026 (USD MILLION) 107
7.3.2.2 Self-expandable stents 107
TABLE 35 SELF-EXPANDABLE STENTS MARKET, BY REGION,
2016–2020 (USD MILLION) 107
TABLE 36 SELF-EXPANDABLE STENTS MARKET, BY REGION,
2021–2026 (USD MILLION) 108
8 CATHETERS MARKET, BY TYPE 109
8.1 INTRODUCTION 110
TABLE 37 CATHETERS MARKET, BY TYPE, 2016–2020 (USD MILLION) 110
TABLE 38 CATHETERS MARKET, BY TYPE, 2021–2026 (USD MILLION) 110
TABLE 39 CATHETERS MARKET, BY REGION, 2016–2020 (USD MILLION) 110
TABLE 40 CATHETERS MARKET, BY REGION, 2021–2026 (USD MILLION) 111
8.2 ANGIOGRAPHY CATHETERS 111
8.2.1 ANGIOGRAPHY CATHETERS TO DOMINATE THE CATHETERS MARKET 111
TABLE 41 ANGIOGRAPHY CATHETERS MARKET, BY REGION,
2016–2020 (USD MILLION) 112
TABLE 42 ANGIOGRAPHY CATHETERS MARKET, BY REGION,
2021–2026 (USD MILLION) 112
 
8.3 GUIDING CATHETERS 112
8.3.1 GUIDING CATHETERS TO ACCOUNT FOR THE SECOND-LARGEST SHARE OF THE CATHETERS MARKET 112
TABLE 43 GUIDING CATHETERS MARKET, BY REGION, 2016–2020 (USD MILLION) 113
TABLE 44 GUIDING CATHETERS MARKET, BY REGION, 2021–2026 (USD MILLION) 113
8.4 IVUS/OCT CATHETERS 113
8.4.1 IVUS/OCT CATHETERS SEGMENT TO REGISTER THE HIGHEST GROWTH RATE 113
TABLE 45 IVUS/OCT CATHETERS MARKET, BY REGION, 2016–2020 (USD MILLION) 114
TABLE 46 IVUS/OCT CATHETERS MARKET, BY REGION, 2021–2026 (USD MILLION) 114
9 ENDOVASCULAR ANEURYSM REPAIR STENT GRAFTS MARKET, BY TYPE 115
9.1 INTRODUCTION 116
TABLE 47 EVAR STENT GRAFTS MARKET, BY TYPE, 2016–2020 (USD MILLION) 116
TABLE 48 EVAR STENT GRAFTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 116
TABLE 49 EVAR STENT GRAFTS MARKET, BY REGION, 2016–2020 (USD MILLION) 116
TABLE 50 EVAR STENT GRAFTS MARKET, BY REGION, 2021–2026 (USD MILLION) 117
9.2 ABDOMINAL AORTIC ANEURYSM STENT GRAFTS 117
9.2.1 ABDOMINAL AORTIC ANEURYSM STENT GRAFTS TO DOMINATE THE MARKET 117
TABLE 51 ABDOMINAL AORTIC ANEURYSM STENT GRAFTS MARKET, BY REGION,
2016–2020 (USD MILLION) 118
TABLE 52 ABDOMINAL AORTIC ANEURYSM STENT GRAFTS MARKET, BY REGION,
2021–2026 (USD MILLION) 118
9.3 THORACIC AORTIC ANEURYSM STENT GRAFTS 118
9.3.1 INCREASING INCIDENCE OF THORACIC AORTIC ANEURYSMS TO DRIVE MARKET GROWTH IN THE COMING YEARS 118
TABLE 53 THORACIC AORTIC ANEURYSM STENT GRAFTS MARKET, BY REGION,
2016–2020 (USD MILLION) 119
TABLE 54 THORACIC AORTIC ANEURYSM STENT GRAFTS MARKET, BY REGION,
2021–2026 (USD MILLION) 119
10 INFERIOR VENA CAVA FILTERS MARKET, BY TYPE 120
10.1 INTRODUCTION 121
TABLE 55 INFERIOR VENA CAVA FILTERS MARKET, BY TYPE, 2016–2020 (USD MILLION) 121
TABLE 56 INFERIOR VENA CAVA FILTERS MARKET, BY TYPE, 2021–2026 (USD MILLION) 121
TABLE 57 INFERIOR VENA CAVA FILTERS MARKET, BY REGION,
2016–2020 (USD MILLION) 121
TABLE 58 INFERIOR VENA CAVA FILTERS MARKET, BY REGION,
2021–2026 (USD MILLION) 122
10.2 RETRIEVABLE FILTERS 122
10.2.1 RETRIEVABLE FILTERS SEGMENT TO REGISTER A HIGHER GROWTH RATE 122
TABLE 59 RETRIEVABLE INFERIOR VENA CAVA FILTERS MARKET, BY REGION,
2016–2020 (USD MILLION) 122
TABLE 60 RETRIEVABLE INFERIOR VENA CAVA FILTERS MARKET, BY REGION,
2021–2026 (USD MILLION) 123
 
10.3 PERMANENT FILTERS 123
10.3.1 RISKS ASSOCIATED WITH PERMANENT FILTERS TO HAMPER THEIR SALES DURING THE FORECAST PERIOD 123
TABLE 61 PERMANENT INFERIOR VENA CAVA FILTERS MARKET, BY REGION,
2016–2020 (USD MILLION) 123
TABLE 62 PERMANENT INFERIOR VENA CAVA FILTERS MARKET, BY REGION,
2021–2026 (USD MILLION) 124
11 PLAQUE MODIFICATION DEVICES MARKET, BY TYPE 125
11.1 INTRODUCTION 126
TABLE 63 PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2016–2020 (USD MILLION) 126
TABLE 64 PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2021–2026 (USD MILLION) 126
TABLE 65 PLAQUE MODIFICATION DEVICES MARKET, BY REGION,
2016–2020 (USD MILLION) 126
TABLE 66 PLAQUE MODIFICATION DEVICES MARKET, BY REGION,
2021–2026 (USD MILLION) 127
11.2 ATHERECTOMY DEVICES 127
11.2.1 INCREASING INCIDENCE OF ATHEROSCLEROSIS AS A RESULT OF THE RISING GLOBAL PREVALENCE OF OBESITY TO DRIVE THE MARKET 127
TABLE 67 ATHERECTOMY DEVICES MARKET, BY REGION, 2016–2020 (USD MILLION) 128
TABLE 68 ATHERECTOMY DEVICES MARKET, BY REGION, 2021–2026 (USD MILLION) 128
11.3 THROMBECTOMY DEVICES 128
11.3.1 GROWING DVT INCIDENCE TO DRIVE THE ADOPTION OF THROMBECTOMY DEVICES 128
TABLE 69 THROMBECTOMY DEVICES MARKET, BY REGION, 2016–2020 (USD MILLION) 129
TABLE 70 THROMBECTOMY DEVICES MARKET, BY REGION, 2021–2026 (USD MILLION) 129
12 HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE 130
12.1 INTRODUCTION 131
TABLE 71 HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE,
2016–2020 (USD MILLION) 131
TABLE 72 HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE,
2021–2026 (USD MILLION) 131
12.2 EMBOLIC PROTECTION DEVICES 131
12.2.1 INCREASING INVESTMENTS IN NEW TECHNOLOGY AND INCREASING REGULATORY APPROVALS TO DRIVE MARKET GROWTH 131
TABLE 73 EMBOLIC PROTECTION DEVICES MARKET, BY REGION,
2016–2020 (USD MILLION) 132
TABLE 74 EMBOLIC PROTECTION DEVICES MARKET, BY REGION,
2021–2026 (USD MILLION) 132
12.3 CHRONIC TOTAL OCCLUSION (CTO) DEVICES 133
12.3.1 INCREASING INVESTMENTS IN THE DEVELOPMENT OF CTO DEVICES TO DRIVE MARKET GROWTH 133
TABLE 75 CHRONIC TOTAL OCCLUSION DEVICES MARKET, BY REGION,
2016–2020 (USD MILLION) 133
TABLE 76 CHRONIC TOTAL OCCLUSION DEVICES MARKET, BY REGION,
2021–2026 (USD MILLION) 133
13 OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE 134
13.1 INTRODUCTION 135
TABLE 77 OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE,
2016–2020 (USD MILLION) 135
TABLE 78 OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE,
2021–2026 (USD MILLION) 135
TABLE 79 OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY REGION,
2016–2020 (USD MILLION) 136
TABLE 80 OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY REGION,
2021–2026 (USD MILLION) 136
13.2 GUIDEWIRES 136
TABLE 81 GUIDEWIRES MARKET, BY REGION, 2016–2020 (USD MILLION) 137
TABLE 82 GUIDEWIRES MARKET, BY REGION, 2021–2026 (USD MILLION) 137
13.3 VASCULAR CLOSURE DEVICES 137
TABLE 83 VASCULAR CLOSURE DEVICES MARKET, BY REGION,
2016–2020 (USD MILLION) 138
TABLE 84 VASCULAR CLOSURE DEVICES MARKET, BY REGION,
2021–2026 (USD MILLION) 138
13.4 INTRODUCER SHEATHS 138
TABLE 85 INTRODUCER SHEATHS MARKET, BY REGION, 2016–2020 (USD MILLION) 139
TABLE 86 INTRODUCER SHEATHS MARKET, BY REGION, 2021–2026 (USD MILLION) 139
13.5 BALLOON INFLATION DEVICES 139
TABLE 87 BALLOON INFLATION DEVICES MARKET, BY REGION,
2016–2020 (USD MILLION) 140
TABLE 88 BALLOON INFLATION DEVICES MARKET, BY REGION,
2021–2026 (USD MILLION) 140
14 PERIPHERAL VASCULAR DEVICES MARKET, BY REGION 141
14.1 INTRODUCTION 142
TABLE 89 PERIPHERAL VASCULAR DEVICES MARKET, BY REGION,
2016–2020 (USD MILLION) 142
TABLE 90 PERIPHERAL VASCULAR DEVICES MARKET, BY REGION,
2021–2026 (USD MILLION) 142
14.2 NORTH AMERICA 143
FIGURE 30 NORTH AMERICA: MARKET SNAPSHOT 143
TABLE 91 NORTH AMERICA: PERIPHERAL VASCULAR DEVICES MARKET, BY COUNTRY, 2016–2020 (USD MILLION) 144
TABLE 92 NORTH AMERICA: PERIPHERAL VASCULAR DEVICES MARKET, BY COUNTRY, 2021–2026 (USD MILLION) 144
TABLE 93 NORTH AMERICA: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2016–2020 (USD MILLION) 144
TABLE 94 NORTH AMERICA: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2021–2026 (USD MILLION) 145
TABLE 95 NORTH AMERICA: ANGIOPLASTY STENTS MARKET, BY TYPE,
2016–2020 (USD MILLION) 145
TABLE 96 NORTH AMERICA: ANGIOPLASTY STENTS MARKET, BY TYPE,
2021–2026 (USD MILLION) 145
TABLE 97 NORTH AMERICA: CATHETERS MARKET, BY TYPE, 2016–2020 (USD MILLION) 146
TABLE 98 NORTH AMERICA: CATHETERS MARKET, BY TYPE, 2021–2026 (USD MILLION) 146
TABLE 99 NORTH AMERICA: EVAR STENT GRAFTS MARKET, BY TYPE,
2016–2020 (USD MILLION) 146
TABLE 100 NORTH AMERICA: EVAR STENT GRAFTS MARKET, BY TYPE,
2021–2026 (USD MILLION) 147
TABLE 101 NORTH AMERICA: IVC FILTERS MARKET, BY TYPE, 2016–2020 (USD MILLION) 147
TABLE 102 NORTH AMERICA: IVC FILTERS MARKET, BY TYPE, 2021–2026 (USD MILLION) 147
TABLE 103 NORTH AMERICA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2016–2020 (USD MILLION) 147
TABLE 104 NORTH AMERICA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2021–2026 (USD MILLION) 148
TABLE 105 NORTH AMERICA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET,
BY TYPE, 2016–2020 (USD MILLION) 148
TABLE 106 NORTH AMERICA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET,
BY TYPE, 2021–2026 (USD MILLION) 148
TABLE 107 NORTH AMERICA: OTHER PERIPHERAL VASCULAR DEVICES MARKET,
BY TYPE, 2016–2020 (USD MILLION) 149
TABLE 108 NORTH AMERICA: OTHER PERIPHERAL VASCULAR DEVICES MARKET,
BY TYPE, 2021–2026 (USD MILLION) 149
14.2.1 FAVORABLE REIMBURSEMENT SCENARIO TO ENSURE DEVICE
ADOPTION IN THE US 149
TABLE 109 US: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2016–2020 (USD MILLION) 151
TABLE 110 US: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2021–2026 (USD MILLION) 151
TABLE 111 US: ANGIOPLASTY STENTS MARKET, BY TYPE, 2016–2020 (USD MILLION) 151
TABLE 112 US: ANGIOPLASTY STENTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 152
TABLE 113 US: CATHETERS MARKET, BY TYPE, 2016–2020 (USD MILLION) 152
TABLE 114 US: CATHETERS MARKET, BY TYPE, 2021–2026 (USD MILLION) 152
TABLE 115 US: EVAR STENT GRAFTS MARKET, BY TYPE, 2016–2020 (USD MILLION) 153
TABLE 116 US: EVAR STENT GRAFTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 153
TABLE 117 US: IVC FILTERS MARKET, BY TYPE, 2016–2020 (USD MILLION) 153
TABLE 118 US: IVC FILTERS MARKET, BY TYPE, 2021–2026 (USD MILLION) 153
TABLE 119 US: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2016–2020 (USD MILLION) 154
TABLE 120 US: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2021–2026 (USD MILLION) 154
TABLE 121 US: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE,
2016–2020 (USD MILLION) 154
TABLE 122 US: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE,
2021–2026 (USD MILLION) 155
TABLE 123 US: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE,
2016–2020 (USD MILLION) 155
TABLE 124 US: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE,
2021–2026 (USD MILLION) 155
14.2.2 CANADA 156
14.2.2.1 Rising prevalence of target diseases to drive market growth 156
TABLE 125 CANADA: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2016–2020 (USD MILLION) 156
TABLE 126 CANADA: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2021–2026 (USD MILLION) 156
TABLE 127 CANADA: ANGIOPLASTY STENTS MARKET, BY TYPE,
2016–2020 (USD MILLION) 157
TABLE 128 CANADA: ANGIOPLASTY STENTS MARKET, BY TYPE,
2021–2026 (USD MILLION) 157
TABLE 129 CANADA: CATHETERS MARKET, BY TYPE, 2016–2020 (USD MILLION) 157
TABLE 130 CANADA: CATHETERS MARKET, BY TYPE, 2021–2026 (USD MILLION) 158
TABLE 131 CANADA: EVAR STENT GRAFTS MARKET, BY TYPE,
2016–2020 (USD MILLION) 158
TABLE 132 CANADA: EVAR STENT GRAFTS MARKET, BY TYPE,
2021–2026 (USD MILLION) 158
TABLE 133 CANADA: IVC FILTERS MARKET, BY TYPE, 2016–2020 (USD MILLION) 159
TABLE 134 CANADA: IVC FILTERS MARKET, BY TYPE, 2021–2026 (USD MILLION) 159
TABLE 135 CANADA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2016–2020 (USD MILLION) 159
TABLE 136 CANADA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2021–2026 (USD MILLION) 160
TABLE 137 CANADA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2016–2020 (USD MILLION) 160
TABLE 138 CANADA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2021–2026 (USD MILLION) 160
TABLE 139 CANADA: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE,
2016–2020 (USD MILLION) 161
TABLE 140 CANADA: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE,
2021–2026 (USD MILLION) 161
14.3 EUROPE 161
TABLE 141 EUROPE: PERIPHERAL VASCULAR DEVICES MARKET, BY COUNTRY,
2016–2020 (USD MILLION) 162
TABLE 142 EUROPE: PERIPHERAL VASCULAR DEVICES MARKET, BY COUNTRY,
2021–2026 (USD MILLION) 162
TABLE 143 EUROPE: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2016–2020 (USD MILLION) 163
TABLE 144 EUROPE: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2021–2026 (USD MILLION) 163
TABLE 145 EUROPE: ANGIOPLASTY STENTS MARKET, BY TYPE,
2016–2020 (USD MILLION) 163
TABLE 146 EUROPE: ANGIOPLASTY STENTS MARKET, BY TYPE,
2021–2026 (USD MILLION) 163
TABLE 147 EUROPE: CATHETERS MARKET, BY TYPE, 2016–2020 (USD MILLION) 164
TABLE 148 EUROPE: CATHETERS MARKET, BY TYPE, 2021–2026 (USD MILLION) 164
TABLE 149 EUROPE: EVAR STENT GRAFTS MARKET, BY TYPE, 2016–2020 (USD MILLION) 164
TABLE 150 EUROPE: EVAR STENT GRAFTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 164
TABLE 151 EUROPE: IVC FILTERS MARKET, BY TYPE, 2016–2020 (USD MILLION) 165
TABLE 152 EUROPE: IVC FILTERS MARKET, BY TYPE, 2021–2026 (USD MILLION) 165
TABLE 153 EUROPE: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2016–2020 (USD MILLION) 165
TABLE 154 EUROPE: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2021–2026 (USD MILLION) 165
TABLE 155 EUROPE: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2016–2020 (USD MILLION) 166
TABLE 156 EUROPE: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2021–2026 (USD MILLION) 166
TABLE 157 EUROPE: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE,
2016–2020 (USD MILLION) 166
TABLE 158 EUROPE: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE,
2021–2026 (USD MILLION) 167
14.3.1 GERMANY 167
14.3.1.1 Increase in geriatric and obese populations contribute to device demand 167
TABLE 159 GERMANY: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2016–2020 (USD MILLION) 168
TABLE 160 GERMANY: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2021–2026 (USD MILLION) 168
TABLE 161 GERMANY: ANGIOPLASTY STENTS MARKET, BY TYPE,
2016–2020 (USD MILLION) 168
TABLE 162 GERMANY: ANGIOPLASTY STENTS MARKET, BY TYPE,
2021–2026 (USD MILLION) 168
TABLE 163 GERMANY: CATHETERS MARKET, BY TYPE, 2016–2020 (USD MILLION) 169
TABLE 164 GERMANY: CATHETERS MARKET, BY TYPE, 2021–2026 (USD MILLION) 169
TABLE 165 GERMANY: EVAR STENT GRAFTS MARKET, BY TYPE,
2016–2020 (USD MILLION) 169
TABLE 166 GERMANY: EVAR STENT GRAFTS MARKET, BY TYPE,
2021–2026 (USD MILLION) 169
TABLE 167 GERMANY: IVC FILTERS MARKET, BY TYPE, 2016–2020 (USD MILLION) 170
TABLE 168 GERMANY: IVC FILTERS MARKET, BY TYPE, 2021–2026 (USD MILLION) 170
TABLE 169 GERMANY: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2016–2020 (USD MILLION) 170
TABLE 170 GERMANY: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2021–2026 (USD MILLION) 170
TABLE 171 GERMANY: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2016–2020 (USD MILLION) 171
TABLE 172 GERMANY: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2021–2026 (USD MILLION) 171
TABLE 173 GERMANY: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2016–2020 (USD MILLION) 171
TABLE 174 GERMANY: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2021–2026 (USD MILLION) 172
14.3.2 FRANCE 172
14.3.2.1 Incidence of PE and DVT to increase owing to the growth of France’s geriatric population 172
TABLE 175 FRANCE: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2016–2020 (USD MILLION) 173
TABLE 176 FRANCE: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2021–2026 (USD MILLION) 173
TABLE 177 FRANCE: ANGIOPLASTY STENTS MARKET, BY TYPE,
2016–2020 (USD MILLION) 173
TABLE 178 FRANCE: ANGIOPLASTY STENTS MARKET, BY TYPE,
2021–2026 (USD MILLION) 173
TABLE 179 FRANCE: CATHETERS MARKET, BY TYPE, 2016–2020 (USD MILLION) 174
TABLE 180 FRANCE: CATHETERS MARKET, BY TYPE, 2021–2026 (USD MILLION) 174
TABLE 181 FRANCE: EVAR STENT GRAFTS MARKET, BY TYPE, 2016–2020 (USD MILLION) 174
TABLE 182 FRANCE: EVAR STENT GRAFTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 174
TABLE 183 FRANCE: IVC FILTERS MARKET, BY TYPE, 2016–2020 (USD MILLION) 175
TABLE 184 FRANCE: IVC FILTERS MARKET, BY TYPE, 2021–2026 (USD MILLION) 175
TABLE 185 FRANCE: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2016–2020 (USD MILLION) 175
TABLE 186 FRANCE: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2021–2026 (USD MILLION) 175
TABLE 187 FRANCE: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2016–2020 (USD MILLION) 176
TABLE 188 FRANCE: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2021–2026 (USD MILLION) 176
TABLE 189 FRANCE: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE,
2016–2020 (USD MILLION) 176
TABLE 190 FRANCE: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE,
2021–2026 (USD MILLION) 177
14.3.3 UK 177
14.3.3.1 Increasing incidence of peripheral vascular diseases to support market growth in the UK 177
TABLE 191 UK: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2016–2020 (USD MILLION) 178
TABLE 192 UK: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2021–2026 (USD MILLION) 178
TABLE 193 UK: ANGIOPLASTY STENTS MARKET, BY TYPE, 2016–2020 (USD MILLION) 178
TABLE 194 UK: ANGIOPLASTY STENTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 179
TABLE 195 UK: CATHETERS MARKET, BY TYPE, 2016–2020 (USD MILLION) 179
TABLE 196 UK: CATHETERS MARKET, BY TYPE, 2021–2026 (USD MILLION) 179
TABLE 197 UK: EVAR STENT GRAFTS MARKET, BY TYPE, 2016–2020 (USD MILLION) 179
TABLE 198 UK: EVAR STENT GRAFTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 180
TABLE 199 UK: IVC FILTERS MARKET, BY TYPE, 2016–2020 (USD MILLION) 180
TABLE 200 UK: IVC FILTERS MARKET, BY TYPE, 2021–2026 (USD MILLION) 180
TABLE 201 UK: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2016–2020 (USD MILLION) 180
TABLE 202 UK: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2021–2026 (USD MILLION) 181
TABLE 203 UK: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE,
2016–2020 (USD MILLION) 181
TABLE 204 UK: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE,
2021–2026 (USD MILLION) 181
TABLE 205 UK: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE,
2016–2020 (USD MILLION) 182
TABLE 206 UK: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE,
2021–2026 (USD MILLION) 182
14.3.4 SPAIN 182
14.3.4.1 Rising geriatric population to increase the demand for peripheral vascular devices 182
TABLE 207 SPAIN: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2016–2020 (USD MILLION) 183
TABLE 208 SPAIN: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2021–2026 (USD MILLION) 183
TABLE 209 SPAIN: ANGIOPLASTY STENTS MARKET, BY TYPE, 2016–2020 (USD MILLION) 183
TABLE 210 SPAIN: ANGIOPLASTY STENTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 184
TABLE 211 SPAIN: CATHETERS MARKET, BY TYPE, 2016–2020 (USD MILLION) 184
TABLE 212 SPAIN: CATHETERS MARKET, BY TYPE, 2021–2026 (USD MILLION) 184
TABLE 213 SPAIN: EVAR STENT GRAFTS MARKET, BY TYPE, 2016–2020 (USD MILLION) 184
TABLE 214 SPAIN: EVAR STENT GRAFTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 185
TABLE 215 SPAIN: IVC FILTERS MARKET, BY TYPE, 2016–2020 (USD MILLION) 185
TABLE 216 SPAIN: IVC FILTERS MARKET, BY TYPE, 2021–2026 (USD MILLION) 185
TABLE 217 SPAIN: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2016–2020 (USD MILLION) 185
TABLE 218 SPAIN: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2021–2026 (USD MILLION) 186
TABLE 219 SPAIN: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2016–2020 (USD MILLION) 186
TABLE 220 SPAIN: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2021–2026 (USD MILLION) 186
TABLE 221 SPAIN: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE,
2016–2020 (USD MILLION) 187
TABLE 222 SPAIN: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE,
2021–2026 (USD MILLION) 187
14.3.5 ITALY 187
14.3.5.1 Increasing health expenditure and rising diabetes prevalence to drive market growth 187
TABLE 223 ITALY: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2016–2020 (USD MILLION) 188
TABLE 224 ITALY: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2021–2026 (USD MILLION) 188
TABLE 225 ITALY: ANGIOPLASTY STENTS MARKET, BY TYPE, 2016–2020 (USD MILLION) 188
TABLE 226 ITALY: ANGIOPLASTY STENTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 189
TABLE 227 ITALY: CATHETERS MARKET, BY TYPE, 2016–2020 (USD MILLION) 189
TABLE 228 ITALY: CATHETERS MARKET, BY TYPE, 2021–2026 (USD MILLION) 189
TABLE 229 ITALY: EVAR STENT GRAFTS MARKET, BY TYPE, 2016–2020 (USD MILLION) 189
TABLE 230 ITALY: EVAR STENT GRAFTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 190
TABLE 231 ITALY: IVC FILTERS MARKET, BY TYPE, 2016–2020 (USD MILLION) 190
TABLE 232 ITALY: IVC FILTERS MARKET, BY TYPE, 2021–2026 (USD MILLION) 190
TABLE 233 ITALY: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2016–2020 (USD MILLION) 190
TABLE 234 ITALY: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2021–2026 (USD MILLION) 191
TABLE 235 ITALY: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE,
2016–2020 (USD MILLION) 191
TABLE 236 ITALY: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE,
2021–2026 (USD MILLION) 191
TABLE 237 ITALY: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE,
2016–2020 (USD MILLION) 192
TABLE 238 ITALY: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE,
2021–2026 (USD MILLION) 192
14.3.6 REST OF EUROPE 192
TABLE 239 ROE: HEALTHCARE EXPENDITURE, BY COUNTRY, 2010 VS. 2018 (% OF GDP) 193
TABLE 240 ROE: PERCENTAGE OF GERIATRIC POPULATION TO THE TOTAL POPULATION, BY COUNTRY, 2015 VS. 2030 (MILLION) 193
TABLE 241 ROE: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2016–2020 (USD MILLION) 194
TABLE 242 ROE: ANGIOPLASTY BALLOONS MARKET, BY TYPE,
2021–2026 (USD MILLION) 194
TABLE 243 ROE: ANGIOPLASTY STENTS MARKET, BY TYPE, 2016–2020 (USD MILLION) 194
TABLE 244 ROE: ANGIOPLASTY STENTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 194
TABLE 245 ROE: CATHETERS MARKET, BY TYPE, 2016–2020 (USD MILLION) 195
TABLE 246 ROE: CATHETERS MARKET, BY TYPE, 2021–2026 (USD MILLION) 195
TABLE 247 ROE: EVAR STENT GRAFTS MARKET, BY TYPE, 2016–2020 (USD MILLION) 195
TABLE 248 ROE: EVAR STENT GRAFTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 196
TABLE 249 ROE: IVC FILTERS MARKET, BY TYPE, 2016–2020 (USD MILLION) 196
TABLE 250 ROE: IVC FILTERS MARKET, BY TYPE, 2021–2026 (USD MILLION) 196
TABLE 251 ROE: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2016–2020 (USD MILLION) 196
TABLE 252 ROE: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
2021–2026 (USD MILLION) 197
TABLE 253 ROE: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE,
2016–2020 (USD MILLION) 197
TABLE 254 ROE: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE,
2021–2026 (USD MILLION) 197
TABLE 255 ROE: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE,
2016–2020 (USD MILLION) 198
TABLE 256 ROE: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE,
2021–2026 (USD MILLION) 198
14.4 ASIA PACIFIC 198
FIGURE 31 ASIA PACIFIC: MARKET SNAPSHOT 199
TABLE 257 ASIA PACIFIC: PERIPHERAL VASCULAR DEVICES MARKET, BY COUNTRY, 2016–2020 (USD MILLION) 200
TABLE 258 ASIA PACIFIC: PERIPHERAL VASCULAR DEVICES MARKET, BY COUNTRY, 2021–2026 (USD MILLION) 200
TABLE 259 ASIA PACIFIC: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 
2016–2020 (USD MILLION) 200
TABLE 260 ASIA PACIFIC: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 
2021–2026 (USD MILLION) 201
TABLE 261 ASIA PACIFIC: ANGIOPLASTY STENTS MARKET, BY TYPE,
 2016–2020 (USD MILLION) 201
TABLE 262 ASIA PACIFIC: ANGIOPLASTY STENTS MARKET, BY TYPE, 
2021–2026 (USD MILLION) 201
TABLE 263 ASIA PACIFIC: CATHETERS MARKET, BY TYPE, 2016–2020 (USD MILLION) 201
TABLE 264 ASIA PACIFIC: CATHETERS MARKET, BY TYPE, 2021–2026 (USD MILLION) 202
TABLE 265 ASIA PACIFIC: EVAR STENT GRAFTS MARKET, BY TYPE, 
2016–2020 (USD MILLION) 202
TABLE 266 ASIA PACIFIC: EVAR STENT GRAFTS MARKET, BY TYPE, 
2021–2026 (USD MILLION) 202
TABLE 267 ASIA PACIFIC: IVC FILTERS MARKET, BY TYPE, 2016–2020 (USD MILLION) 202
TABLE 268 ASIA PACIFIC: IVC FILTERS MARKET, BY TYPE, 2021–2026 (USD MILLION) 203
TABLE 269 ASIA PACIFIC: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 
2016–2020 (USD MILLION) 203
TABLE 270 ASIA PACIFIC: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 
2021–2026 (USD MILLION) 203
TABLE 271 ASIA PACIFIC: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, 
BY TYPE, 2016–2020 (USD MILLION) 204
TABLE 272 ASIA PACIFIC: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, 
BY TYPE, 2021–2026 (USD MILLION) 204
TABLE 273 ASIA PACIFIC: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2016–2020 (USD MILLION) 204
TABLE 274 ASIA PACIFIC: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2021–2026 (USD MILLION) 205
14.4.1 JAPAN 205
14.4.1.1 Presence of a large geriatric population to support market growth 205
TABLE 275 JAPAN: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 
2016–2020 (USD MILLION) 206
TABLE 276 JAPAN: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 
2021–2026 (USD MILLION) 206
TABLE 277 JAPAN: ANGIOPLASTY STENTS MARKET, BY TYPE, 2016–2020 (USD MILLION) 206
TABLE 278 JAPAN: ANGIOPLASTY STENTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 206
TABLE 279 JAPAN: CATHETERS MARKET, BY TYPE, 2016–2020 (USD MILLION) 207
TABLE 280 JAPAN: CATHETERS MARKET, BY TYPE, 2021–2026 (USD MILLION) 207
TABLE 281 JAPAN: EVAR STENT GRAFTS MARKET, BY TYPE, 2016–2020 (USD MILLION) 207
TABLE 282 JAPAN: EVAR STENT GRAFTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 207
TABLE 283 JAPAN: IVC FILTERS MARKET, BY TYPE, 2016–2020 (USD MILLION) 208
TABLE 284 JAPAN: IVC FILTERS MARKET, BY TYPE, 2021–2026 (USD MILLION) 208
TABLE 285 JAPAN: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE,
 2016–2020 (USD MILLION) 208
TABLE 286 JAPAN: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 
2021–2026 (USD MILLION) 208
TABLE 287 JAPAN: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2016–2020 (USD MILLION) 209
TABLE 288 JAPAN: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2021–2026 (USD MILLION) 209
TABLE 289 JAPAN: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE,
 2016–2020 (USD MILLION) 209
TABLE 290 JAPAN: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 
2021–2026 (USD MILLION) 210
14.4.2 CHINA 210
14.4.2.1 Growing target patient population to drive market growth 210
TABLE 291 CHINA: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 
2016–2020 (USD MILLION) 211
TABLE 292 CHINA: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 
2021–2026 (USD MILLION) 211
TABLE 293 CHINA: ANGIOPLASTY STENTS MARKET, BY TYPE, 2016–2020 (USD MILLION) 211
TABLE 294 CHINA: ANGIOPLASTY STENTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 211
TABLE 295 CHINA: CATHETERS MARKET, BY TYPE, 2016–2020 (USD MILLION) 212
TABLE 296 CHINA: CATHETERS MARKET, BY TYPE, 2021–2026 (USD MILLION) 212
TABLE 297 CHINA: EVAR STENT GRAFTS MARKET, BY TYPE, 2016–2020 (USD MILLION) 212
TABLE 298 CHINA: EVAR STENT GRAFTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 212
TABLE 299 CHINA: IVC FILTERS MARKET, BY TYPE, 2016–2020 (USD MILLION) 213
TABLE 300 CHINA: IVC FILTERS MARKET, BY TYPE, 2021–2026 (USD MILLION) 213
TABLE 301 CHINA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 
2016–2020 (USD MILLION) 213
TABLE 302 CHINA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 
2021–2026 (USD MILLION) 213
TABLE 303 CHINA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2016–2020 (USD MILLION) 214
TABLE 304 CHINA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2021–2026 (USD MILLION) 214
TABLE 305 CHINA: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 
2016–2020 (USD MILLION) 214
TABLE 306 CHINA: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 
2021–2026 (USD MILLION) 215
14.4.3 INDIA 215
14.4.3.1 Increasing prevalence of diabetes to drive the adoption of peripheral vascular devices 215
TABLE 307 INDIA: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 
2016–2020 (USD MILLION) 216
TABLE 308 INDIA: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 
2021–2026 (USD MILLION) 216
TABLE 309 INDIA: ANGIOPLASTY STENTS MARKET, BY TYPE, 2016–2020 (USD MILLION) 216
TABLE 310 INDIA: ANGIOPLASTY STENTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 216
TABLE 311 INDIA: CATHETERS MARKET, BY TYPE, 2016–2020 (USD MILLION) 217
TABLE 312 INDIA: CATHETERS MARKET, BY TYPE, 2021–2026 (USD MILLION) 217
TABLE 313 INDIA: EVAR STENT GRAFTS MARKET, BY TYPE, 2016–2020 (USD MILLION) 217
TABLE 314 INDIA: EVAR STENT GRAFTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 217
TABLE 315 INDIA: IVC FILTERS MARKET, BY TYPE, 2016–2020 (USD MILLION) 218
TABLE 316 INDIA: IVC FILTERS MARKET, BY TYPE, 2021–2026 (USD MILLION) 218
TABLE 317 INDIA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 
2016–2020 (USD MILLION) 218
TABLE 318 INDIA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 
2021–2026 (USD MILLION) 218
TABLE 319 INDIA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 
2016–2020 (USD MILLION) 219
TABLE 320 INDIA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 
2021–2026 (USD MILLION) 219
TABLE 321 INDIA: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 
2016–2020 (USD MILLION) 219
TABLE 322 INDIA: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 
2021–2026 (USD MILLION) 220
14.4.4 REST OF ASIA PACIFIC 220
TABLE 323 REST OF ASIA PACIFIC: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 
2016–2020 (USD MILLION) 221
TABLE 324 REST OF ASIA PACIFIC: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 
2021–2026 (USD MILLION) 221
TABLE 325 REST OF ASIA PACIFIC: ANGIOPLASTY STENTS MARKET, BY TYPE, 
2016–2020 (USD MILLION) 221
TABLE 326 REST OF ASIA PACIFIC: ANGIOPLASTY STENTS MARKET, BY TYPE, 
2021–2026 (USD MILLION) 222
TABLE 327 REST OF ASIA PACIFIC: CATHETERS MARKET, BY TYPE, 
2016–2020 (USD MILLION) 222
TABLE 328 REST OF ASIA PACIFIC: CATHETERS MARKET, BY TYPE, 
2021–2026 (USD MILLION) 222
TABLE 329 REST OF ASIA PACIFIC: EVAR STENT GRAFTS MARKET, BY TYPE,
 2016–2020 (USD MILLION) 223
TABLE 330 REST OF ASIA PACIFIC: EVAR STENT GRAFTS MARKET, BY TYPE, 
2021–2026 (USD MILLION) 223
TABLE 331 REST OF ASIA PACIFIC: IVC FILTERS MARKET, BY TYPE, 
2016–2020 (USD MILLION) 223
TABLE 332 REST OF ASIA PACIFIC: IVC FILTERS MARKET, BY TYPE, 
2021–2026 (USD MILLION) 223
TABLE 333 REST OF ASIA PACIFIC: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2016–2020 (USD MILLION) 224
TABLE 334 REST OF ASIA PACIFIC: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2021–2026 (USD MILLION) 224
TABLE 335 REST OF ASIA PACIFIC: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2016–2020 (USD MILLION) 224
TABLE 336 REST OF ASIA PACIFIC: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2021–2026 (USD MILLION) 225
TABLE 337 REST OF ASIA PACIFIC: OTHER PERIPHERAL VASCULAR DEVICES MARKET, 
BY TYPE, 2016–2020 (USD MILLION) 225
TABLE 338 REST OF ASIA PACIFIC: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2021–2026 (USD MILLION) 225
 
14.5 REST OF THE WORLD 226
TABLE 339 ROW: PERIPHERAL VASCULAR DEVICES MARKET, BY REGION, 
2016–2020 (USD MILLION) 226
TABLE 340 ROW: PERIPHERAL VASCULAR DEVICES MARKET, BY REGION, 
2021–2026 (USD MILLION) 226
TABLE 341 ROW: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 
2016–2020 (USD MILLION) 226
TABLE 342 ROW: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 
2021–2026 (USD MILLION) 227
TABLE 343 ROW: ANGIOPLASTY STENTS MARKET, BY TYPE, 2016–2020 (USD MILLION) 227
TABLE 344 ROW: ANGIOPLASTY STENTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 227
TABLE 345 ROW: CATHETERS MARKET, BY TYPE, 2016–2020 (USD MILLION) 227
TABLE 346 ROW: CATHETERS MARKET, BY TYPE, 2021–2026 (USD MILLION) 228
TABLE 347 ROW: EVAR STENT GRAFTS MARKET, BY TYPE, 2016–2020 (USD MILLION) 228
TABLE 348 ROW: EVAR STENT GRAFTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 228
TABLE 349 ROW: IVC FILTERS MARKET, BY TYPE, 2016–2020 (USD MILLION) 228
TABLE 350 ROW: IVC FILTERS MARKET, BY TYPE, 2021–2026 (USD MILLION) 229
TABLE 351 ROW: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 
2016–2020 (USD MILLION) 229
TABLE 352 ROW: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 
2021–2026 (USD MILLION) 229
TABLE 353 ROW: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 
2016–2020 (USD MILLION) 229
TABLE 354 ROW: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 
2021–2026 (USD MILLION) 230
TABLE 355 ROW: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 
2016–2020 (USD MILLION) 230
TABLE 356 ROW: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 
2021–2026 (USD MILLION) 230
14.5.1 LATIN AMERICA 231
TABLE 357 LATIN AMERICA: PERIPHERAL VASCULAR DEVICES MARKET, BY COUNTRY, 2016–2020 (USD MILLION) 231
TABLE 358 LATIN AMERICA: PERIPHERAL VASCULAR DEVICES MARKET, BY COUNTRY, 2021–2026 (USD MILLION) 232
TABLE 359 LATIN AMERICA: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 
2016–2020 (USD MILLION) 232
TABLE 360 LATIN AMERICA: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 
2021–2026 (USD MILLION) 232
TABLE 361 LATIN AMERICA: ANGIOPLASTY STENTS MARKET, BY TYPE, 
2016–2020 (USD MILLION) 233
TABLE 362 LATIN AMERICA: ANGIOPLASTY STENTS MARKET, BY TYPE, 
2021–2026 (USD MILLION) 233
TABLE 363 LATIN AMERICA: CATHETERS MARKET, BY TYPE, 2016–2020 (USD MILLION) 233
TABLE 364 LATIN AMERICA: CATHETERS MARKET, BY TYPE, 2021–2026 (USD MILLION) 233
TABLE 365 LATIN AMERICA: EVAR STENT GRAFTS MARKET, BY TYPE, 
2016–2020 (USD MILLION) 234
TABLE 366 LATIN AMERICA: EVAR STENT GRAFTS MARKET, BY TYPE, 
2021–2026 (USD MILLION) 234
TABLE 367 LATIN AMERICA: IVC FILTERS MARKET, BY TYPE, 2016–2020 (USD MILLION) 234
TABLE 368 LATIN AMERICA: IVC FILTERS MARKET, BY TYPE, 2021–2026 (USD MILLION) 234
TABLE 369 LATIN AMERICA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 
2016–2020 (USD MILLION) 235
TABLE 370 LATIN AMERICA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 
2021–2026 (USD MILLION) 235
TABLE 371 LATIN AMERICA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, 
BY TYPE, 2016–2020 (USD MILLION) 235
TABLE 372 LATIN AMERICA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, 
BY TYPE, 2021–2026 (USD MILLION) 236
TABLE 373 LATIN AMERICA: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2016–2020 (USD MILLION) 236
TABLE 374 LATIN AMERICA: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2021–2026 (USD MILLION) 236
14.5.1.1 Brazil 237
14.5.1.1.1 Brazil to dominate the Latin American peripheral vascular devices market 237
TABLE 375 BRAZIL: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 
2016–2020(USD MILLION) 237
TABLE 376 BRAZIL: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 
2021–2026 (USD MILLION) 237
TABLE 377 BRAZIL: ANGIOPLASTY STENTS MARKET, BY TYPE, 
2016–2020 (USD MILLION) 238
TABLE 378 BRAZIL: ANGIOPLASTY STENTS MARKET, BY TYPE, 
2021–2026 (USD MILLION) 238
TABLE 379 BRAZIL: CATHETERS MARKET, BY TYPE, 2016–2020 (USD MILLION) 238
TABLE 380 BRAZIL: CATHETERS MARKET, BY TYPE, 2021–2026 (USD MILLION) 238
TABLE 381 BRAZIL: EVAR STENT GRAFTS MARKET, BY TYPE, 2016–2020 (USD MILLION) 239
TABLE 382 BRAZIL: EVAR STENT GRAFTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 239
TABLE 383 BRAZIL: IVC FILTERS MARKET, BY TYPE, 2016–2020 (USD MILLION) 239
TABLE 384 BRAZIL: IVC FILTERS MARKET, BY TYPE, 2021–2026 (USD MILLION) 239
TABLE 385 BRAZIL: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 
2016–2020 (USD MILLION) 240
TABLE 386 BRAZIL: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 
2021–2026 (USD MILLION) 240
TABLE 387 BRAZIL: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2016–2020 (USD MILLION) 240
TABLE 388 BRAZIL: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2021–2026 (USD MILLION) 240
TABLE 389 BRAZIL: OTHER PERIPHERAL VASCULAR DEVICES MARKET, 
BY TYPE, 2016–2020 (USD MILLION) 241
TABLE 390 BRAZIL: OTHER PERIPHERAL VASCULAR DEVICES MARKET, 
BY TYPE, 2026–2026 (USD MILLION) 241
14.5.1.2 Mexico 241
14.5.1.2.1 Mexico to account for the second-largest share in the Latin American peripheral vascular devices market 241
TABLE 391 MEXICO: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 
2016–2020 (USD MILLION) 242
TABLE 392 MEXICO: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 
2021–2026 (USD MILLION) 242
TABLE 393 MEXICO: ANGIOPLASTY STENTS MARKET, BY TYPE, 
2016–2020 (USD MILLION) 242
TABLE 394 MEXICO: ANGIOPLASTY STENTS MARKET, BY TYPE, 
2021–2026 (USD MILLION) 243
TABLE 395 MEXICO: CATHETERS MARKET, BY TYPE, 2016–2020 (USD MILLION) 243
TABLE 396 MEXICO: CATHETERS MARKET, BY TYPE, 2021–2026 (USD MILLION) 243
TABLE 397 MEXICO: EVAR STENT GRAFTS MARKET, BY TYPE, 2016–2020 (USD MILLION) 243
TABLE 398 MEXICO: EVAR STENT GRAFTS MARKET, BY TYPE, 2021–2026 (USD MILLION) 244
TABLE 399 MEXICO: IVC FILTERS MARKET, BY TYPE, 2016–2020 (USD MILLION) 244
TABLE 400 MEXICO: IVC FILTERS MARKET, BY TYPE, 2021–2026 (USD MILLION) 244
TABLE 401 MEXICO: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 
2016–2020 (USD MILLION) 244
TABLE 402 MEXICO: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 
2021–2026 (USD MILLION) 245
TABLE 403 MEXICO: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2016–2020 (USD MILLION) 245
TABLE 404 MEXICO: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2021–2026 (USD MILLION) 245
TABLE 405 MEXICO: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 
2016–2020 (USD MILLION) 246
TABLE 406 MEXICO: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 
2021–2026 (USD MILLION) 246
14.5.1.3 Colombia 246
14.5.1.3.1 Increasing prevalence of peripheral artery diseases to support market growth 246
TABLE 407 COLOMBIA: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 
2016–2020 (USD MILLION) 247
TABLE 408 COLOMBIA: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 
2021–2026 (USD MILLION) 247
TABLE 409 COLOMBIA: ANGIOPLASTY STENTS MARKET, BY TYPE, 
2016–2020 (USD MILLION) 247
TABLE 410 COLOMBIA: ANGIOPLASTY STENTS MARKET, BY TYPE, 
2021–2026 (USD MILLION) 247
TABLE 411 COLOMBIA: CATHETERS MARKET, BY TYPE, 2016–2020 (USD MILLION) 248
TABLE 412 COLOMBIA: CATHETERS MARKET, BY TYPE, 2021–2026 (USD MILLION) 248
TABLE 413 COLOMBIA: EVAR STENT GRAFTS MARKET, BY TYPE, 
2016–2020 (USD MILLION) 248
TABLE 414 COLOMBIA: EVAR STENT GRAFTS MARKET, BY TYPE, 
2021–2026 (USD MILLION) 248
TABLE 415 COLOMBIA: IVC FILTERS MARKET, BY TYPE, 2016–2020 (USD MILLION) 249
TABLE 416 COLOMBIA: IVC FILTERS MARKET, BY TYPE, 2021–2026 (USD MILLION) 249
TABLE 417 COLOMBIA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 
2016–2020 (USD MILLION) 249
TABLE 418 COLOMBIA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 
2021–2026 (USD MILLION) 249
TABLE 419 COLOMBIA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2016–2020 (USD MILLION) 250
TABLE 420 COLOMBIA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2021–2026 (USD MILLION) 250
TABLE 421 COLOMBIA: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2016–2020 (USD MILLION) 250
TABLE 422 COLOMBIA: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2021–2026 (USD MILLION) 251
14.5.1.4 Argentina 251
14.5.1.4.1 Increasing prevalence of obesity to support market growth 251
TABLE 423 ARGENTINA: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 
2016–2020 (USD MILLION) 251
TABLE 424 ARGENTINA: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 
2021–2026 (USD MILLION) 252
TABLE 425 ARGENTINA: ANGIOPLASTY STENTS MARKET, BY TYPE, 
2016–2020 (USD MILLION) 252
TABLE 426 ARGENTINA: ANGIOPLASTY STENTS MARKET, BY TYPE, 
2021–2026 (USD MILLION) 252
TABLE 427 ARGENTINA: CATHETERS MARKET, BY TYPE, 2016–2020 (USD MILLION) 252
TABLE 428 ARGENTINA: CATHETERS MARKET, BY TYPE, 2021–2026 (USD MILLION) 253
TABLE 429 ARGENTINA: EVAR STENT GRAFTS MARKET, BY TYPE, 
2016–2020 (USD MILLION) 253
TABLE 430 ARGENTINA: EVAR STENT GRAFTS MARKET, BY TYPE, 
2021–2026 (USD MILLION) 253
TABLE 431 ARGENTINA: IVC FILTERS MARKET, BY TYPE, 2016–2020 (USD MILLION) 253
TABLE 432 ARGENTINA: IVC FILTERS MARKET, BY TYPE, 2021–2026 (USD MILLION) 254
TABLE 433 ARGENTINA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 
2016–2020 (USD MILLION) 254
TABLE 434 ARGENTINA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 
2021–2026 (USD MILLION) 254
TABLE 435 ARGENTINA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2016–2020 (USD MILLION) 255
TABLE 436 ARGENTINA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2021–2026 (USD MILLION) 255
TABLE 437 ARGENTINA: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2016–2020 (USD MILLION) 255
TABLE 438 ARGENTINA: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2021–2026 (USD MILLION) 256
14.5.1.5 Rest of Latin America 256
TABLE 439 REST OF LATIN AMERICA: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2016–2020 (USD MILLION) 256
TABLE 440 REST OF LATIN AMERICA: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 2021–2026 (USD MILLION) 256
TABLE 441 REST OF LATIN AMERICA: ANGIOPLASTY STENTS MARKET, BY TYPE, 
2016–2020 (USD MILLION) 257
TABLE 442 REST OF LATIN AMERICA: ANGIOPLASTY STENTS MARKET, BY TYPE, 
2021–2026 (USD MILLION) 257
TABLE 443 REST OF LATIN AMERICA: CATHETERS MARKET, BY TYPE, 
2016–2020 (USD MILLION) 257
TABLE 444 REST OF LATIN AMERICA: CATHETERS MARKET, BY TYPE, 
2021–2026 (USD MILLION) 258
TABLE 445 REST OF LATIN AMERICA: EVAR STENT GRAFTS MARKET, BY TYPE, 
2016–2020 (USD MILLION) 258
TABLE 446 REST OF LATIN AMERICA: EVAR STENT GRAFTS MARKET, BY TYPE, 
2021–2026 (USD MILLION) 258
TABLE 447 REST OF LATIN AMERICA: IVC FILTERS MARKET, BY TYPE, 
2016–2020 (USD MILLION) 259
TABLE 448 REST OF LATIN AMERICA: IVC FILTERS MARKET, BY TYPE, 
2021–2026 (USD MILLION) 259
TABLE 449 REST OF LATIN AMERICA: PLAQUE MODIFICATION DEVICES MARKET, 
BY TYPE, 2016–2020 (USD MILLION) 259
TABLE 450 REST OF LATIN AMERICA: PLAQUE MODIFICATION DEVICES MARKET, 
BY TYPE, 2021–2026 (USD MILLION) 259
TABLE 451 REST OF LATIN AMERICA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2016–2020 (USD MILLION) 260
TABLE 452 REST OF LATIN AMERICA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2021–2026 (USD MILLION) 260
TABLE 453 REST OF LATIN AMERICA: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2016–2020 (USD MILLION) 260
TABLE 454 REST OF LATIN AMERICA: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2021–2026 (USD MILLION) 261
14.5.2 MIDDLE EAST & AFRICA 261
14.5.2.1 Increasing prevalence of diabetes to drive market growth 261
TABLE 455 MIDDLE EAST & AFRICA: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 
2016–2020 (USD MILLION) 262
TABLE 456 MIDDLE EAST & AFRICA: ANGIOPLASTY BALLOONS MARKET, BY TYPE, 
2021–2026 (USD MILLION) 262
TABLE 457 MIDDLE EAST & AFRICA: ANGIOPLASTY STENTS MARKET, BY TYPE, 
2016–2020 (USD MILLION) 262
TABLE 458 MIDDLE EAST & AFRICA: ANGIOPLASTY STENTS MARKET, BY TYPE, 
2021–2026 (USD MILLION) 263
TABLE 459 MIDDLE EAST & AFRICA: CATHETERS MARKET, BY TYPE, 
2016–2020 (USD MILLION) 263
TABLE 460 MIDDLE EAST & AFRICA: CATHETERS MARKET, BY TYPE, 
2021–2026 (USD MILLION) 263
TABLE 461 MIDDLE EAST & AFRICA: EVAR STENT GRAFTS MARKET, BY TYPE, 
2016–2020 (USD MILLION) 264
TABLE 462 MIDDLE EAST & AFRICA: EVAR STENT GRAFTS MARKET, BY TYPE, 
2021–2026 (USD MILLION) 264
TABLE 463 MIDDLE EAST & AFRICA: IVC FILTERS MARKET, BY TYPE, 
2016–2020 (USD MILLION) 264
TABLE 464 MIDDLE EAST & AFRICA: IVC FILTERS MARKET, BY TYPE, 
2021–2026 (USD MILLION) 264
TABLE 465 MIDDLE EAST & AFRICA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2016–2020 (USD MILLION) 265
TABLE 466 MIDDLE EAST & AFRICA: PLAQUE MODIFICATION DEVICES MARKET, BY TYPE, 2021–2026 (USD MILLION) 265
TABLE 467 MIDDLE EAST & AFRICA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2016-2019 (USD MILLION) 265
TABLE 468 MIDDLE EAST & AFRICA: HEMODYNAMIC FLOW ALTERATION DEVICES MARKET, BY TYPE, 2021–2026 (USD MILLION) 266
TABLE 469 MIDDLE EAST & AFRICA: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2016–2020 (USD MILLION) 266
TABLE 470 MIDDLE EAST & AFRICA: OTHER PERIPHERAL VASCULAR DEVICES MARKET, BY TYPE, 2021–2026 (USD MILLION) 266
15 COMPETITIVE LANDSCAPE 267
15.1 OVERVIEW 267
15.2 KEY PLAYER STRATEGIES/RIGHT TO WIN 267
TABLE 471 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN THE PERIPHERAL VASCULAR DEVICES MARKET 267
15.3 MARKET SHARE ANALYSIS 268
TABLE 472 PERIPHERAL VASCULAR DEVICES MARKET: DEGREE OF COMPETITION 268
15.4 COMPANY EVALUATION MATRIX 269
15.4.1 STARS 269
15.4.2 EMERGING LEADERS 269
15.4.3 PERVASIVE PLAYERS 269
15.4.4 PARTICIPANTS 269
FIGURE 32 COMPANY EVALUATION MATRIX: PERIPHERAL VASCULAR DEVICES MARKET 270
15.5 COMPANY EVALUATION MATRIX (SMES/START-UPS) 271
15.5.1 PROGRESSIVE COMPANIES 271
15.5.2 STARTING BLOCKS 271
15.5.3 RESPONSIVE COMPANIES 271
15.5.4 DYNAMIC COMPANIES 271
FIGURE 33 COMPANY EVALUATION MATRIX: PERIPHERAL VASCULAR DEVICES MARKET (SMES & START-UPS) 272
15.6 COMPANY FOOTPRINT ANALYSIS 273
TABLE 473 OVERALL FOOTPRINT OF COMPANIES IN THE PERIPHERAL VASCULAR DEVICES MARKET 273
TABLE 474 PRODUCT FOOTPRINT OF COMPANIES 274
15.7 COMPETITIVE SCENARIO 276
 
16 COMPANY PROFILES 280
16.1 KEY PLAYERS 280
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
16.1.1 MEDTRONIC 280
TABLE 475 MEDTRONIC: BUSINESS OVERVIEW 280
FIGURE 34 MEDTRONIC: COMPANY SNAPSHOT (2020) 281
16.1.2 BOSTON SCIENTIFIC CORPORATION 286
TABLE 476 BOSTON SCIENTIFIC CORPORATION: BUSINESS OVERVIEW 286
FIGURE 35 BOSTON SCIENTIFIC: COMPANY SNAPSHOT (2020) 287
16.1.3 ABBOTT 291
TABLE 477 ABBOTT: BUSINESS OVERVIEW 291
FIGURE 36 ABBOTT: COMPANY SNAPSHOT (2020) 292
16.1.4 BECTON, DICKINSON AND COMPANY 295
TABLE 478 BECTON, DICKINSON AND COMPANY: BUSINESS OVERVIEW 295
FIGURE 37 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT (2020) 296
16.1.5 TERUMO CORPORATION 299
TABLE 479 TERUMO CORPORATION: BUSINESS OVERVIEW 299
FIGURE 38 TERUMO CORPORATION: COMPANY SNAPSHOT (2020) 300
16.1.6 CORDIS (A SUBSIDIARY OF CARDINAL HEALTH) 303
TABLE 480 CORDIS: BUSINESS OVERVIEW 303
FIGURE 39 CARDINAL HEALTH: COMPANY SNAPSHOT (2020) 304
16.1.7 B. BRAUN MELSUNGEN AG 308
TABLE 481 B. BRAUN MELSUNGEN AG: BUSINESS OVERVIEW 308
FIGURE 40 B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT (2020) 309
16.1.8 MERIT MEDICAL SYSTEMS 311
TABLE 482 MERIT MEDICAL SYSTEMS: BUSINESS OVERVIEW 311
FIGURE 41 MERIT MEDICAL: COMPANY SNAPSHOT (2020) 312
16.1.9 PENUMBRA, INC. 314
TABLE 483 PENUMBRA, INC: BUSINESS OVERVIEW 314
FIGURE 42 PENUMBRA, INC.: COMPANY SNAPSHOT (2020) 315
16.1.10 KONINKLIJKE PHILIPS N.V. 317
TABLE 484 KONINKLIJKE PHILIPS N.V.: BUSINESS OVERVIEW 317
FIGURE 43 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2020) 318
16.1.11 IVASCULAR S.L.U. 320
TABLE 485 IVASCULAR S.L.U.: BUSINESS OVERVIEW 320
16.1.12 BIOSENSORS INTERNATIONAL GROUP, LTD. 322
TABLE 486 BIOSENSORS INTERNATIONAL GROUP, LTD.: BUSINESS OVERVIEW 322
16.1.13 BIOTRONIK 323
TABLE 487 BIOTRONIK: BUSINESS OVERVIEW 323
16.1.14 AMG INTERNATIONAL GMBH (A SUBSIDIARY OF Q3 MEDICAL) 325
TABLE 488 AMG INTERNATIONAL: BUSINESS OVERVIEW 325
16.1.15 ENDOCOR GMBH 326
TABLE 489 ENDOCOR GMBH: BUSINESS OVERVIEW 326
16.2 START-UPS/SME PLAYERS 328
16.2.1 MERIL LIFE SCIENCES PVT. LTD. 328
TABLE 490 MERIL LIFE SCIENCES PVT.LTD.: COMPANY OVERVIEW 328
16.2.2 ALVIMEDICA 329
TABLE 491 ALVIMEDICA: COMPANY OVERVIEW 329
16.2.4 CARDIONOVUM GMBH 330
TABLE 492 CARDIONOVUM GMBH: COMPANY OVERVIEW 330
16.2.6 SMT 331
TABLE 493 SMT: COMPANY OVERVIEW 331
16.2.8 MEDINOL LTD. 332
TABLE 494 MEDINOL LTD.: COMPANY OVERVIEW 332
16.2.9 ANDRAMED GMBH. 333
TABLE 495 ANDRAMED GMBH: COMPANY OVERVIEW 333
16.2.10 COOK 334
TABLE 496 COOK: COMPANY OVERVIEW 334
16.2.12 REX MEDICAL 336
TABLE 497 REX MEDICAL: COMPANY OVERVIEW 336
16.2.14 QMD 337
TABLE 498 QMD.: COMPANY OVERVIEW 337
16.2.15 BROSMED MEDICAL 338
TABLE 499 BROSMED MEDICAL: COMPANY OVERVIEW 338
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
17 APPENDIX 339
17.1 DISCUSSION GUIDE 339
17.2 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 344
17.3 AVAILABLE CUSTOMIZATIONS 346
17.4 RELATED REPORTS 346
17.5 AUTHOR DETAILS 347

　

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（電子カルテ、HER）の最新刊レポート

MarketsandMarkets社の電子カルテ、HER分野での最新刊レポート

本レポートと同じKEY WORD（devices）の最新刊レポート


よくあるご質問


MarketsandMarkets社はどのような調査会社ですか?


マーケッツアンドマーケッツ（MarketsandMarkets）は通信、半導体、医療機器、エネルギーなど、幅広い市場に関する調査レポートを出版しています。また広範な市場を対象としたカスタム調査も行って... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

お問合せはこちらから

03-3582-2531

電話お問合せもお気軽に

 

2024/11/21　10:26

156.13 円

165.08 円

200.38 円

ページTOPに戻る

株式会社 データリソース　Data Resources, Inc.
東京都港区赤坂1-14-5　アークヒルズエグゼクティブタワー N313

電話：03-3582-2531
FAX：03-3582-2861
Eメール：office@dri.co.jp

FAQ サイトマップ プライバシーポリシー お問合せ

関連会社:
株式会社ユーディーアール

COPYRIGHT(C) 2011-2023　DATA RESOURCES, Inc. ALL RIGHTS RESERVED.